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Abstract 
A comprehensive substance abuse treatment facility began observing increased admissions who 
reported histories of bariatric surgeries.  The present study examined what unique variables may 
pose risk for substance abuse among bariatric surgery candidates and what issues may affect 
prognosis or treatment outcome for those currently in substance abuse treatment. Participants 
completed a questionnaire and participated in a semi-structured interview. Results indicate that 
post-bariatric patients developed problematic substance use significantly later in life, during a 
time that is not normative of new development of substances; were significantly more likely to 
be diagnosed with alcohol use disorders; and reported a significantly poorer psychological 
quality of life; yet they did not report a greater total number of drinks per drinking day or total 
substances used, and did not endorse greater behavioral excess.  Post-bariatric patients may be 
overrepresented in substance abuse treatment programs, and they may need tailored treatment to 
address their unique characteristics.  
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 Literature Review 
Obesity   
Obesity is a chronic condition characterized by an excessively high proportion of body 
fat stores (Formiguera & Canton, 2004). Excess body fat is operationalized as greater than or 
equal to 25% of body fat in women and 18% in men (Bray, 1998). Although it is possible to 
measure body fat, it is a difficult, impractical, and cost prohibitive task; currently, there are no 
established parameters of body fat. To examine population-based estimates of obesity, the World 
Health Organization (WHO) created the Body Mass Index (BMI), which defines weight 
classifications based on weight and height (see Table 1). BMI is calculated by dividing 
individuals’ weight in kilograms by the square of their height in meters. A BMI greater than or 
equal to 25 kg/m² is classified as overweight, while a BMI greater than or equal to 30 kg/m² is 
considered obese. A BMI ranging from 18.5 to 24.9 kg/m² constitutes normal weight. There are 
several alternatives to measuring obesity; however, BMI is the WHO’s recommended form of 
measurement for adults. It is widely used because of its empirical support with respect to 
identifying medical complications associated with obesity and is an inexpensive and practical 
system for classification for obesity research (Manson, Skerrett, & Willet, 2002).  
Obesity is the number one cause of preventable death in the United States and considered 
an epidemic (Sturm, 2002). Using BMI, the US Department of Health and Human Services 
reports that 66% of Americans are overweight, including the 34% of Americans who are obese 
(United States Department of Health and Human Services, 2008). These statistics convert to 
roughly 129.6 million people in the United States who are overweight or obese. The WHO 
estimates that over a billion people worldwide are overweight and 300 million are considered 
obese. These statistics are expected to double in the next 20 years (Formiguera & Canton, 2004). 
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Notably, the prevalence of overweight individuals has stayed relatively stable in the last 20 
years, while the rate of obesity has risen dramatically (Flegal, Carroll, Ogden, & Curtin, 2010; 
Flegal, Carroll, Ogden, & Johnson, 2002).  
Morbid Obesity  
Additionally, the rate of severe or morbid obesity is increasing faster than moderate 
obesity (Sturm, 2003; Sturm, 2007). The prevalence of morbid obesity, otherwise known as 
Obesity Class III (see Table 1), quadrupled in the United States from 1986 to 2000 (Sturm, 
2003), and from 2000 to 2005, the rates increased from 24% to 50%, respectively (Sturm, 2007).  
Table 1  
Classification of Adult Obesity 
Classification                                        BMI (kg/m²)                            Risk of comorbidities 
Normal range 18.5-24.9 Average 
Overweight ≥25.0 Increased 
Preobesity 25.0-29.9 Increased 
Obesity class I 30.00-34.99 Moderate 
Obesity class II 35.00-39.9 Severe 
Obesity class III ≥40.00 Very Severe 
As BMI increases, morbidity and mortality rates increase (see Table 1). Obesity is 
associated with many adverse health complications including type two diabetes, certain cancers, 
gallstones, osteoarthritis, hypertension, stroke, dyslipidemia, respiratory disease, gout, increased 
rates of cardiovascular disease, obstructive sleep apnea, kidney disease, glucose intolerance, 
progressive liver disease, and obesity-related cancers (e.g., colon, breast, esophageal, uterine, 
ovarian, kidney and pancreatic; Eckel, 2008; Must et al., 1999; Pi-Sunyer, 2002). Obesity affects 
nearly every organ and system in the body. The health concerns associated with obesity clearly 
warrant further research addressing this epidemic.  
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Obesity and Psychological Functioning  
Morbid obesity is not only associated with myriad health-related consequences but is also 
associated with a poorer quality of life (Kolotkin, Meter, & Williams, 2001). Kolotkin and 
colleagues state: “Both physical functioning and psychosocial functioning are negatively 
impacted by excess weight, with greater impairments associated with greater degrees of obesity” 
(p. 225). Furthermore, there appears to be an inverse relationship between BMI and health-
related quality of life (Chang, Hung, Chang, Tai, Lin, & Wang, 2008; van Nunen, Wouters, 
Vingerhoets, Hox, & Geenen, 2007). Specifically, those seeking surgical treatment for obesity 
tend to report a poorer quality of life than the general population (van Nunen, Wouters, 
Vingerhoets, Hox, & Geenen, 2007). A recent study conducted in Taiwan compared morbidly 
obese patients seeking surgical weight loss treatment to matched healthy controls and found 
significant differences in overall quality of life as well as health-related and physical, 
psychological, and social quality of life, suggesting this relationship appears to hold even across 
cultures (Chang, Hung, Chang, Tai, Lin, & Wang, 2008).  
Although the obese report a poorer quality of life in several domains of quality of life, 
less evidence supports any relationship between obesity and psychopathology (Stunkdard & 
Wadden, 1999). It is well known that the obese are more likely to report a negative body image, 
are more prone to distort their body image (Jones, Grilo, Masheb, & White, 2009), and report 
less satisfaction and greater preoccupation with their physical appearance. However, most 
studies that compare obese and non-obese groups find comparable rates of psychiatric problems 
(Stunkdard & Wadden, 1999; Friedman & Brownell, 2002). An exception to this is evidence 
from several population-based studies that found a positive association between major 
depression and obesity (Petry, Barry, Pietrzak, & Wagner, 2008), particularly among women 
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(Pickering, Grant, Chou, & Compton, 2007; Scott, McGee, Wells, & Oakley Browne, 2008; 
Simon et al., 2006). A notable and consistent finding, however, is the elevated rates of 
psychopathology among obese patients seeking weight loss surgery (Abiles et al., 2008; 
Fitzgibbon, Stolley, & Kirschenbaum, 1993; Kalarchian et al., 2007; Kolotkin et al., 2003; 
Roberts, Kaplan, Shema, & Strawbridge, 2000); these findings will be extensively reviewed 
later. Negative body image dissatisfaction, concerns about physical appearance, and self-reported 
depression related to weight status are central reasons why people seek treatment (Rosen, 2002). 
However, the combination of psychological distress and health-related conditions may influence 
many overweight or obese to seek weight loss treatment, rather than psychiatric care.  
Treatment for Obesity: Weight Loss Programs 
 Several literature reviews conclude that weight loss is associated with improvements in 
many dimensions of life, including the physical, psychological, and social domains (Fontaine & 
Barofsky, 2001; Foster & Wadden, 2002; Kolotkin, Meter, & Williams, 2001; Kushner & Foster, 
2000). Even modest or short-term weight losses are associated with improvements in mood, self-
esteem, energy, and quality of life (Brownell & Wadden, 1992; Fontaine et al., 1999). 
Consequently, many obese persons enroll in various weight loss programs for both health-related 
and psychological reasons. These programs (e.g., behavioral weight loss, commercial, 
pharmacological, and surgical treatment) and data regarding their typical outcomes are reviewed 
below. 
Behavioral Weight Loss (BWL)  
Behavioral weight loss programs teach patients skills to achieve weight loss, and the 
goals of treatment are to modify eating habits and increase physical activity (Foster, Makris, & 
Bailer, 2005). Specifically, BWL programs tend to focus on restricting caloric consumption and 
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increasing exercise by achieving small changes rather than large or drastic changes in behavior. 
These programs typically include strategies such as goal-setting, self-monitoring, stimulus 
control, cognitive restructuring, and relapse prevention (i.e., prevention of weight re-gain) 
(Foster, Makris, & Bailer, 2005). Several studies, however, conclude that very few in BWL 
programs reach their ideal or goal weight (Wadden, Sternberg, Letizia, Stunkdard, & Foster, 
1989; Wadden, Stunkard, & Liebschutz, 1988). The average weight loss ranges from 15-20 kg 
during the first 12 weeks of treatment (an average weight loss of 7-10% of body weight within 
the 16- to 24-week treatment phase (Brownell & Wadden, 1992; Wilson & Brownell, 2002). 
Treatment outcome studies, however, tend to find dramatic fluctuations and significant weight-
regain, with approximately one-third of treatment-maintained weight loss regained at one-year 
follow-up (Wilson & Brownell, 2002). Studies that examine a longer treatment duration tend to 
find that the majority of patients are unable to lose more than 10-15% of total body weight for 
the duration, and the majority of studies find weight maintenance with only modest weight loss 
results (Wilson & Brownell, 2002; Brownell & Wadden, 1992). In general, studies that examine 
a longer follow-up tend to find a return to baseline weight (Wadden, Stunkard, & Liebschutz, 
1988; Wadden et al., 1989). For instance, Wadden and colleagues (1988) examined BWL 
subjects who had received either a very low calorie diet, behavior therapy, or a combined 
treatment, and found that three years after treatment the average subject in all BWL conditions 
regained a range of 74% and 85% of their final treatment weight loss, and there were no 
significant differences between the groups. BWL programs have been extensively researched, 
with the consensus being that BWL outcomes are generally unsuccessful in providing long-term 
weight loss.  
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Commercial Weight Loss Programs  
While BWL programs have been extensively researched, very few patients use them 
outside of university settings (Brownell & Wadden, 1992; Wadden, Brownell, & Foster, 2002). 
More frequently, overweight and obese individuals tend to use commercial or self-help weight 
loss programs (e.g., Jenny Craig, Weight Watchers), which tend to provide social support rather 
than medical care as treatment (Womble & Wadden, 2002). These programs are rarely evaluated 
empirically. One exception by Lowe and colleagues (2001) examined long-term weight loss 
outcome of participants of a Weight Watchers program who had previously achieved their goal 
weight upon completion. At one year post-treatment, the reported weight regain was consistent 
with results found from clinical studies (i.e., one-third of weight regained at one year). 
Surprisingly, the subjects on average reported a percentage of weight re-gain that was less than 
what is typically reported in research from clinical populations (the sample re-gained 76.5% of 
their initial weight loss at the end of a 5-year investigation). However, several limitations were 
present. The researchers relied entirely on self-report of all the Weight Watchers subjects, in 
addition to selectively sampling patients who endorsed reaching their treatment goal weight. 
Brownell and Wadden (1992) conclude that the safety and effectiveness of commercial programs 
remains unknown.  
Pharmacological Weight Loss Treatment  
The National Institute of Health (NIH, 2000) guidelines support the use of medication for 
patients with a BMI ≥ 30 (or a BMI ≥ 27 with comorbid health conditions), who understand the 
risks and likelihood for success. The NIH suggests changes in lifestyle should be targeted first; 
however, if gains are not made after 6 months, pharmacotherapy may be considered. 
Additionally, the guidelines suggest that medications should only be used within a 
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comprehensive treatment program, which includes diet, physical activity changes, and behavior 
therapy. The guidelines add that short-term medication use is not an effective form of weight loss 
treatment. Pharmacological treatment for obesity is associated with several side effects, abuse, 
and relapse, and the outcomes for currently available medications provide only modest results 
(Aronne, 2002).   
Weight Loss Surgery  
Weight loss, or bariatric, surgery is currently the most effective weight loss treatment for 
clinically severe or morbid obesity, according to the NIH (2000) guidelines. To undergo bariatric 
surgery, an individual must have a BMI greater than 40, or within the range of 35-39.9 
(moderately obese) with serious medical comorbidities (e.g., diabetes, hypertension).  
Consequently, corresponding to increasing rates of morbid obesity, the number of 
bariatric surgeries performed has increased significantly in recent years. The exact number of 
post-surgical patients in the U.S. is unknown; however, many estimates are documented. From 
1990 to 1997 the estimated number of surgeries performed annually increased from 4,925 to 
12,541, respectively (Pope, Birkmeyer, & Finlayson, 2002). In 2002, Poulose et al. reported an 
estimated 69,490 bariatric operations performed to date, while a year later 103,000 surgeries 
were estimated (Steinbrook, 2004). Smoot and colleagues (2006) examined National Hospital 
discharge data from 1998 through 2002 and concluded that the rate of surgeries performed 
increased significantly over time.  The American Society for Metabolic and Bariatric Surgery 
estimates that 0.4% of those medically eligible in the United States have undergone bariatric 
surgery (ASMBS); however, the dramatic increase in the number of surgeries performed in the 
10 years is clearly evidenced. They estimate that in 2008, roughly 220,000 people received 
weight loss surgery, while in the early 1990s only 16,000 had (ASMBS).  
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Gastric Bypass Surgery  
Although there are various types of surgical weight loss procedures (e.g., horizontal 
gastroplasty, nonadjustable gastric banding, biliopancreatic diversion), there are currently two 
types of procedures which dominate: gastric bypass and gastric-banding. Gastric bypass, which 
was later modified to the Roux-en-Y procedure, is currently the gold standard procedure for 
weight loss surgery. A gastric bypass divides the stomach into a small pouch (about 1-2 tbsp) 
and a larger pouch, and re-arranges the small intestine to connect to both pouches. This 
procedure provides significant weight loss through a combination of gastric restriction and 
malabsorption, through the reconstruction of the stomach to the small intestine (Mitchell & 
Courcoulas, 2005). In other words, the procedure restricts how much food can be eaten and 
creates a rapid sense of satiety shortly after eating. When gastric bypass was later modified to the 
Roux-en Y procedure, the size of the pouch was reduced, which limited many of the adverse 
complications (e.g., nausea, vomiting, and abdominal pain after eating); the Roux-en-Y also 
promoted greater weight loss than previous surgeries (Colquitt, Picot, Loveman, & Clegg, 2009).  
Gastric bypass surgery is the preferred surgical weight loss treatment in the United States, 
while the gastric-banded procedure is more frequently performed in Europe and Australia 
(O’Brien et al., 2002). Gastric-banding is similar to gastric bypass. A small pouch (20 ml) is 
banded, designed to limit the intake; however, in gastric-banding the gastrointestional tract is 
unaltered, so it is designed as a purely restrictive procedure. Although gastric-banding is a highly 
successful weight loss procedure, it appears to be less successful than gastric bypass surgery. 
Three randomized controlled trials have found a statistically significant difference with gastric 
bypass yielding greater weight loss (Howard et al., 1995; Olbers, Fagevik-Olsen, Maleckas, & 
Lonroth, 2005; Sugerman, Starkey, & Birkenhauer, 1987). Some hypothesize that greater weight 
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loss may occur in Roux-en-Y due to greater malabsorption (Sugerman, Londrey, Kellum, Wolf, 
Liszka, & Engle et al., 1989). Additionally, gastric bypass surgery induces “dumping syndrome,” 
or rapid gastric emptying, in many patients. Dumping syndrome causes significant nausea, 
bloating, cramping, diarrhea, dizziness, and fatigue, after the consumption of sweet foods and 
milk products (Hsu et al., 1998). This discourages patients from future consumption of sweets 
which contributes to greater weight loss (Wadden, Brownell, & Foster, 2002).  
 
 
Figure 1. Gastric Bypass and Gastric Banding Procedures  
Weight Loss Outcome after Bariatric Surgery 
Those who undergo bariatric surgery lose a significant amount of excess body weight, 
compared to those who use non-surgical weight loss methods (Buchwald, 2004; Colquitt et al., 
2009; Maggard et al., 2005). Studies have found that obese individuals (e.g., those who are 200% 
overweight) lose at least 50% of excess weight (Stunkard, Stinnett, & Smoller, 1986), and a  
recent meta-analysis examining various surgical treatments for obesity found that bariatric 
Adjustable Band Procedure Roux-en-Y Gastric Bypass Procedure 
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patients lost an average of 61.6% excess weight (Buchwald, 2004). Additionally, the majority of 
patients had a reduction in obesity-related co-morbid conditions such as diabetes, 
hyperlipidemia, hypertension, and sleep apnea, with several conditions eliminated post-surgery 
(Buchwald, 2004). Furthermore, bariatric surgery is associated with a reduction in the usage of 
medications associated with comorbid conditions such as diabetes, hyperlipidemia, hypertension, 
and depression (Sears, Fillmore, Bui, & Rodriguez, 2008). Several comprehensive reviews 
conclude that bariatric surgery is highly effective in promoting weight loss and reducing 
comorbid weight-related health conditions (Buchwald, 2004; Colquitt et al., 2009; Maggard et 
al., 2005).  
Quality of Life following Bariatric Surgery 
Bariatric surgery is associated with improvements in health-related quality of life, a 
construct which taps physical health, emotional well-being, and psychosocial functioning 
(Kolotkin, Crosby, Williams, Hartley, & Nicol, 2001; de Zwaan et al., 2002). Prior to receiving 
surgical treatment, bariatric candidates report a poorer health-related quality of life than those not 
seeking treatment, even after controlling for BMI, age, and gender (Kolotkin, Crosby, & 
Williams, 2002; Kolotkin, Crosby, Pendleton, Strong, Gress, & Adams, 2003). For instance, a 
recent study conducted a follow-up of 75 gastric bypass patients a year after surgery, finding 
significant improvements in health-related quality of life, independent of the amount of weight 
lost (Sears et al., 2008). However, of the 58 patients whose weight loss data were available, an 
average of 52.9 kg was lost. In addition to the small sample size as a limitation, given that the 
majority of patients lost a significant amount of weight, patients who receive successful results 
from surgery may be more motivated to participate in the follow-up procedures, including 
research studies. However, these patients may not be representative of all post-bariatric patients, 
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specifically those who experience weight re-gain, or those who encounter post-surgical 
complications. For instance, although the majority of weight loss patients experience significant 
weight loss, a minority (reported as high as 20%) fail to lose a significant amount (Sarwer, 
Wadden, & Fabricatore, 2005). These patients may not be accurately represented in the current 
literature. A recent report found that 79% of their participants followed after surgery reported 
weight regain (Odom et al., 2010), and among these participants, a “decreased postoperative 
well-being” was an independent predictor of weight regain. Those who do not have favorable 
outcomes (as defined as significant weight loss) from weight loss surgery may report a poorer 
health-related quality of life, a finding that is not reported in the current literature. 
Some hypothesize the improvement in quality of life may dissipate over time (Kodama et 
al., 1998; Sarwer, Wadden, & Fabricatore, 2005). Most follow-up studies tend to be conducted a 
year after surgery, when substantial weight loss typically occurs. A “honeymoon” period may 
occur during that year, and longitudinal findings are rarely examined in the current literature. 
Additionally, suicide has been reported as a major cause of death in post-bariatric patients (Hsu 
et al., 1998). Current data are unavailable; however, a recent report examined self-injurious 
behavior among bariatric candidates and reported that many, nearly 10%, had a history of 
attempted suicide and that 22 out of the 121 candidates reported self-harm and other maladaptive 
behaviors, such as sexual promiscuity and alcohol abuse (Sansone, Wiederman, Schumacher, & 
Routsong-Weichers, 2008). In contract, in a study with a longer follow-up (13-15 years post-
surgery) of 86 gastric bypass patients, there was only one reported case of suicide and one death 
due to chronic alcoholism (Mitchell et al., 2001). Longitudinal studies with larger samples are 
needed to understand quality of life and suicidality in post-bariatric patients. 
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Psychopathology and Bariatric Surgery  
Few studies have examined the role of psychosocial and psychiatric factors in long-term 
outcomes in the bariatric population. Certain factors, however, are recommended as 
contraindications for surgery approval. The American Association of Clinical Endocrinologists 
(AACE), The Obesity Society (TOS), and the American Society for Metabolic and Bariatric 
Surgery (ASMBS) provide guidelines and clinical recommendations for metabolic and bariatric 
surgery, stating: “a psychosocial-behavioral evaluation, which assesses environmental, familial, 
and behavioral factors, should be considered for all patients before bariatric surgery” (p. 324). 
Additionally, the report recommends severe uncontrolled psychiatric illness and current drug or 
alcohol abuse as exclusionary criteria for bariatric surgery (Mechanick, Kushner, & Sugerman et 
al., 2008).  However, during the pre-surgical screening each surgical treatment team decides its 
own psychiatric exclusion criteria, as there is not a clear consensus, with only a handful of 
studies examining possible psychiatric contraindications (Marcus, Kalarchian, & Courcoulas, 
2009; Segal, Libanori, & Azevedo, 2001).  
Few empirical reports have examined the bariatric surgery psychiatric approval process 
itself.  Fabricatore and colleagues (2006) contacted 194 bariatric surgery mental health 
professionals and assessed which psychosocial domains were evaluated in their approval 
procedure and what they considered a contraindication for surgery approval. The survey had 
open and close-ended questions, and the most commonly reported assessed symptoms were 
depression, eating disorders, and anxiety disorders. When asked what they believed was a “clean 
contraindication to surgery,” mental health professionals reported psychiatric issues, non-specific 
mental health issues, eating disorders, mood disorders and substance use disorders. Walfish 
(2007) sampled 103 psychologists through a brief mail survey and found significant variability in 
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the measures used during evaluations as well as reasons for delay or denial of surgery. Fifteen 
percent of the total sample was delayed or denied surgery; the most commonly reported reasons 
were active psychopathology, such as psychosis or bipolar disorder (mentioned 53 times), 
untreated or undertreated depression (mentioned 41 times), or a lack of understanding the risks 
and postoperative requirements of surgery (mentioned 31 times), followed by active substance 
abuse and eating disorders (both mentioned 26 times). Interestingly, although current substance 
abuse was reported 26 times (cited by at least 25% of the total sample), there were no specific 
measures reported by psychologists to assess abuse or dependence criteria. The most commonly 
used measures were the MMPI-2 (Butcher, Dahlstrom, Graham, Tellegen, & Kreammer, 1989), 
followed by the Beck Depression Inventory (Beck, Steer, & Brown, 1996) and the Millon 
Behavioral Medicine Diagnostic (Millon, Green, Meagher, & Millon, 1982). These findings may 
suggest that the majority of candidates receive approval for surgery and that substance use is 
rarely systematically assessed by many psychologists and mental health providers conducting 
pre-surgical evaluations. Mental health professionals seemingly agree that psychiatric issues are 
important to evaluate for surgical approval. However, given that there are currently no definitive 
data as to what psychiatric issues might be a predictor of poor outcome, many clinicians are 
relying on their own judgment when conducting bariatric assessments.  
Psychopathology in Bariatric Surgery Candidates  
Several population-based studies have assessed the rate of psychopathology in bariatric 
candidates using structured clinical interviews assessing DSM-IV-TR diagnoses (Kalarchian et 
al., 2007; Mauri et al., 2008; Mühlhans, Horbach, & de Zwaan, 2009; Rosenberger, Henderson, 
& Grilo, 2006).  High rates of psychopathology are found among surgery candidates. These 
include mood, anxiety (Ali, Rasmussen, Monash, & Fuller, 2009; Kalarchian et al., 2007; Lier, 
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Biringer, Stubhaug, Eriksen, & Tangen, 2010; Mauri et al., 2008; Mühlhans, Horbach, & de 
Zwaan, 2009; Rosenberger, Henderson, & Grilo., 2006; Sarwer et al., 2004), somatization 
(Rosik, 2005), and eating disorders, such as binge eating disorder (Black, Goldstein, & Mason, 
1992; de Zwaan et al., 2003; Kalarchian, Wilson, Brolin, & Bradley, 1998). Not surprisingly, 
studies conducted independent of the pre-surgical psychiatric approval process tend to find 
higher rates of psychopathology (Kalarchian et al., 2007; Mühlhans, Horbach, & de Zwaan, 
2009) than those associated with the approval process (Mauri et al., 2008; Rosenberger, 
Henderson, & Grilo., 2006). These data suggest that bariatric candidates may be underreporting 
symptoms in fear their surgery may not be granted approval.  
Psychopathology in Post-Surgery Patients  
Herpetz and colleagues (2003) reviewed 40 studies examining psychopathology, 
psychosocial functioning, and quality of life among post-bariatric surgery patients and concluded 
that psychological status improves after weight loss surgery. Eight studies examined psychiatric 
comorbidity which typically was assessed by standardized or structured questionnaires as well as 
clinical interviews. Axis I disorders (predominantly affective, anxiety, and eating disorders) were 
considerably less common at follow-up, ranging from no diagnosis to one-half or one-third of 
pre-surgical ratings; however, the rate of personality disorders did not change after surgery. 
Additionally, weight loss was correlated with improvements in psychological variables such as 
psychological stability and self-esteem. 
A high prevalence of binge eating disorder is found among bariatric surgery candidates, 
with prevalence rates ranging from 39-46% (Herpertz et al., 2003). Some researchers suggest 
that binge eating behavior may re-emerge in some patients after surgery (Niego, Kofman, Weiss, 
& Geliebter, 2007). Herpetz et al. (2003) found that the change in Binge Eating Disorder (BED) 
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symptoms after surgery was related to the type of surgery received, yet they concluded that 
overall the surgery is associated with improvements in eating disordered behavior, such as binge 
eating and night eating. Niego and colleagues (2007) reviewed the current literature on binge 
eating in the bariatric population and found that binge eating ceases in many patients after 
surgery, yet it is unclear if or when it may re-emerge after the initial weight loss “honeymoon” 
stage. Additionally, there is considerable debate regarding the DSM-IV-TR binge size, or portion 
criteria for “a large amount of food” among post-bariatric patients. Powers, Perez, Boyd, and 
Rosemurgy (1999) argue that gastric restriction makes binge eating physiologically impossible 
for post-surgery patients due to quick satiety as a consequence of the surgical anatomical 
changes. The authors suspect, however, that binge eating might occur in this population if it were 
physically possible. Some post-bariatric patients who binge eat vomit after satiety (de Zwaan et 
al., 2010), yet post-bariatric patient binge-purge behavior may be uncharacteristic of what 
constitutes a “normal” binge-purge episode, e.g., in bulimia nervosa. It is unclear whether a 
vomit response occurs involuntarily as a weight management mechanism or rather represents a 
compensatory behavior characteristic of bulimia nervosa. Given the physiological constraints of 
bariatric surgery, Niego and colleagues highlight studies that do not include the “large amount of 
food” criteria tend to find binge eating behavior persists in post-bariatric patients, typically 
reemerging 18-35 months post-surgery.  
Given the evidence regarding psychiatric status in post-bariatric patients, it is evident that 
very few studies have long-term follow-up findings. For instance, the majority of studies 
examined in the Herpetz et al. review were conducted two years following surgery. Nonetheless, 
the current data seem to suggest that presurgical psychiatric illness and psychological distress do 
not affect weight loss outcomes. The data also suggest that significant improvements occur in 
  
16 
other areas, including psychological outcomes of the majority of weight loss patients (Burgmer, 
Petersen, Burgmer, de Zwaan, Wolf, & Herpertz, 2007; van Hout, Boekestein, Fortuin, Pelle, & 
Heck, 2006). Longitudinal studies may elucidate whether or not a “honeymoon” period may 
occur following surgery, with a later return to previous functioning.  
Substance Use and Obesity  
As previously discussed, the evidence from population-based studies typically finds that 
obesity is not associated with a greater likelihood of psychological problems. The relationship 
between obesity and substance use, however, yields several inconsistent findings. Petry and 
colleagues (2008) examined data from the National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC) and found that being moderately overweight was associated with 
lifetime alcohol abuse. They did not find a relationship, however, for other substances. In 
contrast, Simon et al. (2006) examined data from the National Comorbidity Survey Replication 
(NCS-R) and did not find a relationship between substance use and weight status. Pickering et al. 
(2007) also used NESARC data and found comparable rates of substance abuse and dependence 
among the obese and non-obese. Using the same data set, Barry and Petry (2009) found an 
increased risk of lifetime alcohol abuse and dependence among overweight and obese men, as 
well as a decreased risk for past-year alcohol abuse in women. Additionally, they found that 
overweight status in women conferred increased risk of lifetime nicotine dependence, while 
obese women were at a decreased risk for past-year nicotine dependence. The methodology used 
in these examinations varies significantly. For instance, Simon and colleagues categorized 
participants into two categories, those with a BMI less than 30 and those with a BMI greater than 
30, while Petry et al. used more specific weight categories (i.e., underweight, normal weight, 
overweight, obese, extremely obese). Pickering et al. examined only past year substance use and 
  
17 
controlled for several comorbid medical conditions and stressful life events, while Barry and 
Petry did not. Particularly given sometimes dramatic differences in how individuals are classified 
into groups with respect to weight status, it is often difficult to draw broad inferences from this 
body of literature as a whole. 
 Nonetheless, substance use affects mechanisms such as appetite, hunger, and food intake.  
Therefore, examining the effect of substance use on eating behavior may allow researchers to 
make inferences that population-based studies do not. For instance, nicotine is an appetite 
suppressant, and cigarette smokers on average tend to weigh 3 to 4kg less than non-smokers 
(Perkins, 1993). Nicotine use is associated with weight loss, while smoking cessation is 
associated with hunger and weight gain (Perkins, 1993). Studies have shown that sucrose tablets 
reduce tobacco-related cravings after smoking cessation, and sugar and carbohydrate intake has 
been associated with a decreased alcohol relapse episode after treatment (Perkins, Levine, 
Marcus, & Shiffman, 1997). Studies like these could point towards common underlying 
mechanisms for substance use and eating behavior.  
Additionally, neurobiological research has identified parallels between food intake and 
substance use by examining brain sites involved in pleasure and reward, specifically with respect 
to cravings (Pelchat, 2002). This evidence will be reviewed later; findings suggest, however, that 
food and drugs of abuse share common reward substrates (Pelchat, 2009). Furthermore, Kleiner 
and colleagues (2003) suggest that drugs of abuse may compete with food for brain reward sites. 
Consequently, excessive eating might function as a substitute for alcohol and other drugs, 
mediating the mechanisms that underlie reward or reinforcement in addiction. 
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Eating and Addiction 
Given the possibly shared mechanisms of food and drug abuse, parallels have also been 
drawn between eating and addictive behaviors—specifically, comparisons of their clinical 
features and of the biological mechanisms involved in both drugs of abuse and the excessive 
consumption of food. For instance, several researchers have emphasized ways in which DSM-
IV-TR criteria and symptoms of BED are similar to substance dependence (Cassin & von 
Ranson, 2007; Davis & Carter, 2008; Ifland et al., 2009). This conceptualization of BED 
suggests that highly palatable foods may have addictive properties, similar to drugs of abuse. In 
particular, the concept of “food addiction” has gained attention in recent media reports, whereby 
substances such as sugar, refined carbohydrates, fat, salt, and caffeine are hypothesized to have 
addictive properties (Corwin & Grigson, 2009; Ifland et al., 2009). Given that behaviors 
associated with obesity (e.g., compulsive overeating) parallel the mechanisms and clinical 
features of substance dependence, several researchers have suggested perhaps binge eating 
specifically should be conceptualized as an addiction rather than an eating disorder (Avena, 
2007; Cassin & von Ranson, 2007; Davis & Carter, 2008). This argument is buttressed by the 
many commonalities in behavioral symptomatology, shared clinical factors, animal models of 
research, and similarities in neurobiology. 
Behavioral Symptomatology 
Binge eating disorder shares many clinical features of substance dependence (see Table 
2). The defining components of addictive behavior are debatable; however, salient features such 
as loss of control, withdrawal, and tolerance are criteria of the DSM-IV-TR diagnosis for 
substance dependence (American Psychiatric Association [APA], 2000). Additionally, craving 
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and relapse are common experiences associated with addiction, although not a feature of the 
formal “dependence” diagnosis (Davis & Carter, 2008).  
Table 2 
Binge Eating Disorder and Substance Dependence Commonalities 
 BED Substance Dependence 
Loss of Control “A sense of lack of control 
over eating during the 
episode” 
“The substance use is 
continued despite knowledge 
of having a persistent or 
recurrent physical or 
psychological problem that is 
likely to have been caused or 
exacerbated by the substance” 
Withdrawal Reported by clinicians 
observing behaviors in 
patients with BED 
Examples: irritability, 
restlessness 
Tolerance “Eating until feeling 
uncomfortably full, eating 
large amounts of food when 
not feeling physically hungry” 
“A need for markedly 
increased amounts of the 
substance to achieve 
intoxication or desired effect, 
markedly diminished effect 
with continued use of the 
same amount of substance” 
Adapted from Davis & Carter, 2009 and Cassin & von Ranson, 2007  
 
“Food addiction” remains a controversial theory; consequently there is reluctance by 
many to classify BED as an addiction rather than an eating disorder. Cassin and von Ranson 
(2007) examined whether binge eating may be experienced as an addiction among women with 
BED. There are no standard criteria by which an “addiction” is assessed; therefore, the authors 
used Goodman’s proposed diagnosis of an “addictive disorder” and the DSM-IV substance 
dependence criteria. DSM criteria were modified to directly pertain to binge eating. For example, 
in the criterion “persistent desire or unsuccessful efforts to control substance use,” substance use 
was changed to “binge eating” to directly compare criteria. The authors found that most binge 
eaters met criteria for dependence (92.4%) but not for “addictive disorder” (40.5%). Participants 
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were most likely to endorse eating larger amounts than intended, continuing to engage in the 
behavior despite knowledge of persistent adverse effects, and having a persistent desire or 
making unsuccessful efforts to stop the behavior, and were less likely to report tolerance and 
withdrawal symptoms. There was also substantial variability in the type of withdrawal symptoms 
reported, including irritability, moodiness, anxiety, restlessness, migraines, insomnia, poor 
concentration, and lethargy.  
Nonetheless, depending on the type of drug of abuse, withdrawal symptoms vary 
significantly. For instance, withdrawal symptoms are relatively uncommon for alcohol addiction, 
while very common for opiate dependence. This variability could also be the case for “food” 
addiction, perhaps depending on the type of food (e.g., sugar versus high-fat foods). Withdrawal 
itself refers to maladaptive physiological changes that occur in an individual who ceases heavy 
use of a substance. Often the physical consequences of withdrawal are the opposite effects of the 
drug’s positive effects. Clinicians working with binge eaters describe withdrawal symptoms 
among that population (McAleavey & Fiumara, 2001). An empirical investigation of this 
phenomenon is warranted; however, many are reluctant to conceptualize food as a drug, 
especially given the variability in the type of food and its psychoactive effects. For example, 
there is a widely held belief that chocolate significantly improves mood, yet this alone does not 
make a strong argument that chocolate is inherently addictive (Rogers & Smit, 2000) or that 
removal of chocolate from a chocolate eater’s diet will create withdrawal-like symptoms.  
The evidence for tolerance among binge eaters remains controversial. Tolerance refers to 
a physiological response by which the desired effect of a drug is decreased after repeated 
exposures. Therefore, an individual increases the dosage to maintain the desired effect. Marlatt 
and Donovan (2005) further characterize tolerance as maintained by environmental cues that 
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elicit a preparatory physiological response and allow individuals to consume more of the drug 
even after the positive effects are diminished. Given the relationship between increased BMI and 
greater severity of binge eating (e.g., frequency of binging, average size of binge episode, and 
binge severity; Picot & Lilenfeld, 2002), this may suggest that “food tolerance” occurs among 
the obese. 
Although not a formal criterion for substance dependence, craving is a commonly 
described phenomenon reported by many substance-using individuals; similarly, food cravings 
have been reported among those with BED (Davis & Carter, 2008), with the assumption that 
cravings influence binge eating and snacking behavior (Pelchat, 2002). Craving is defined 
behaviorally as “increased efforts to obtain a substance of abuse or its associated cues as a result 
of dependence and abstinence” (Avena, Rada, & Hobel, 2008). Furthermore, weight cycling, 
(which is associated with BED; Petroni et al., 2007) has been compared to the experience of 
relapse in substance users. Relapse occurs when a substance user who has experienced a period 
of abstinence encounters a lapse and then re-engages in excessive drug use. Cycles of cessation 
and relapse are common, mirroring a pattern of weight cycling experienced by many dieters and 
binge eaters (Davis & Carter, 2008).  
Loss of control refers to the compulsive use of a substance despite significant adverse 
consequences. These consequences may include psychosocial distress, medical or health 
complications, legal troubles, occupational and financial problems, and poor interpersonal 
relations. Loss of control is also characterized by repeated unsuccessful attempts to cut down use 
or stop entirely. In other words, the individuals continue compulsive use of a substance in the 
midst of significant adverse consequences, and they are unable to cease or control their behavior. 
Colles, Dixon, and O’Brien (2008) suggest that loss of control among binge eaters may cause 
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them to seek out bariatric surgery in an attempt to gain control over their weight and 
psychological disturbances. Bariatric patients were examined pre- and post-surgery, and the 
individuals with pre-surgery BED were more likely to engage in grazing behavior post-surgery. 
There was high overlap between uncontrolled eating and grazing behavior (Colles, Dixon, & 
O’Brien, 2008). Given the comorbidity between binge eating and obesity, there is reason to 
believe that binge eating behavior persists despite adverse consequences (e.g., poor health, 
weight-related stigma and discrimination).  
In summary, the current evidence suggests that there are common features associated 
with obesity (e.g., compulsive overeating) that operate similar to addictive behaviors. Behavioral 
symptoms such as tolerance, withdrawal, craving, and loss of control are often characteristic of 
compulsive overeating or compulsive substance use. Interestingly, Volkow and O’Brien (2007) 
suggest obesity should be classified and treated as not only a metabolic disorder, but a mental 
disorder, also drawing comparisons to substance dependence. However, there is considerable 
debate over its inclusion within the DSM-V. Marcus and Wildes (2009) conclude there is 
insufficient evidence to support the inclusion of obesity as a mental disorder for classification 
within the DSM-V. Future research is necessary to examine whether obesity represents a unique 
condition best understood as an “addiction.”   
Animal Models of Binge Eating 
In animal models, the study of binge eating is limited by a number of subjective factors 
that are not easily assessed. For instance, feelings identified as risk factors in humans, such as 
loss of control, cannot be ascertained in rat behavior. To mimic the phenomenon of binge eating, 
food deprivation is often used to mimic dietary restraint in animal models of research. For 
instance, one study examined rats that were given limited access to palatable, or highly preferred, 
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foods compared to rats given a standard chow diet (Cottone, Sabino, Steardo, & Zorrilla, 2008). 
Following this event, rats were presented with a mere morsel of palatable food and then chow 
(i.e., less preferred food). The rats in the state of deprivation overate or exhibited behaviors 
similar to binge eating in humans including increased consumption (of nearly half of their daily 
caloric intake, a 7-fold increase designed to originally satiate) and displayed anxiety-like 
behavior in response to less preferred foods. The binge size was also correlated with the degree 
of anxiety-like behavior. Furthermore, this binge-like behavior occurs even after a rat has eaten a 
satiating quantity of chow.  The authors suggest that this animal model may mirror similar 
patterns observed in humans, such as theories of restrained eating among individuals with 
anorexia nervosa, bulimia nervosa, or dieters restricting their caloric intake. However, binge 
eating in humans is not necessarily driven by metabolic need, as binge eating is associated with 
obesity and overweight status. 
 Environmental stressors such as negative affect are associated with binge eating in 
humans (Stice, 2001; Engel et al., 2007). Smyth et al. (2007) examined the temporal sequencing 
of binge eating and vomit behavior in women with bulimia and concluded that negative affect 
and stress are more likely to occur prior to a binge or vomit episode. Animal research has 
examined the role of environmental stressors in rats by using stressors such as tail pinching and 
food shock (Corwin & Buda-Levin, 2004). Animal models find that physical and environmental 
stress plays a key role in the maintenance of binge eating behavior. For instance, rats on a 
restricted diet and then exposed to a foot shock and given free access to “preferred” foods eat 
significantly more than rats not on a restricted diet (Hagan, Wauford, Chandler, Jarrett, Rybak, & 
Blackburn, 2002). Implications for human behavior will be discussed below. 
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Addictive-like Animal Models of Binge Eating  
Animal models have also been utilized to experimentally examine the relationship 
between binge eating and addictive behaviors in rats. Avena and colleagues have used sugar as a 
palatable food to examine behavioral and neurochemical responses in rats. For instance, rats 
given an intermittent schedule of sugar and chow (through exposure and deprivation) are used to 
mimic a binge-restraint pattern that is common in people with bulimia (Drewnowski, Krahn, 
Demitrack, Nairn, & Gosnell, 1992). Rats put on an intermittent schedule of a sugar and chow 
diet show a decrease in chow consumption and an increase in the frequency of sugar 
consumption over time, compared to rats given free access to the same amount of food (Avena, 
Rada, & Hobel, 2008). This pattern mimics a “binge” episode that is often characteristic of 
compulsive substance use (Avena, Rada, & Hobel, 2008; Avena, 2007). Furthermore, rats that 
are food deprived and then exposed to a free access diet of glucose that is later removed show 
aggressive withdrawal-like symptoms. These rats exhibit increased withdrawal-like symptoms 
such as teeth chattering, forepaw tremor, and head shaking (Avena, Rada, & Hobel, 2008). This 
research may have implications or translate to some understanding of the human experience for 
eating behaviors and obesity. For instance, Avena and colleagues (2008) suggest that the theory 
of “food addiction” for humans may have some credibility, given the parallels between drugs of 
abuse and palatable foods found in rats.  Although animal research may be useful in exploring 
the similar effects of eating behavior in humans, there are obvious limitations in drawing such 
parallels.  Humans are not artificially put on intermittent schedules of sugar and chow; however, 
there is evidence that using this paradigm in rats may produce binge behavior, opiate-like 
withdrawal symptoms, which therefore may cause neurochemical changes that are similar among 
humans (Avena, 2007).   
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Neurobiology 
The endogenous opioid systems are involved in many kinds of drug use, and it is now 
generally accepted that endogenous opiates mediate the rewarding effects for food as well 
(Pelchat, 2002; Mercer & Holder, 1997). The reward pathways of endogenous opioids, as well as 
dopaminergic brain reward circuits, are associated with overeating and drug use (Mathes, 
Brownley, Mo, & Bulik, 2009; Petroni et al., 2007). This evidence also indicates that highly 
palatable foods eaten in excessive amounts cause neuroadaptations, thus increasing compulsive 
use and cravings, and contributing to symptoms of withdrawal.  Therefore, increased exposure to 
rewards (by food) can contribute to similar responses to those observed with drug addiction 
(Davis & Carter, 2008).  This has also been observed among those with BED and bulimia 
nervosa (Drewnowski, Krahn, Demitrack, Nairn, & Gosnell, 1995). For instance, an opiate 
antagonist, Naloxone, suppressed the consumption of sweet high-fat food among those who 
engaged in binge eating, and this effect was independent of BMI.  Additionally, evidence 
conducted from brain imaging studies suggests that dysregulation of particular neural circuits  
has been observed among obese individuals compared to lean individuals, which may be 
associated with compulsive behaviors such as overeating (Volkow et al., 2001).  Humans all 
have the same reward pathways, but clearly not all become overweight or obese.  
Neuroadaptations in conjunction with individual differences in physiological responsiveness to 
food and the environment may contribute to a greater likelihood of obesity.  For instance, Rodin 
(1985) suggests that those who are more reactive to food may become obese due to an increase 
in insulin production, which may consequently shift one’s metabolism towards fat storage.  Thus, 
obesity is likely due to complex biological and physiological factors, which may also play a role 
in other forms of excessive behavior.          
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Bariatric Surgery and Substance Use 
The overlap between eating and addictive behavior suggests that post-bariatric patients 
may be at increased risk for addiction-related complications following surgery. However, few 
studies have thoroughly examined rates of substance use disorders in those seeking bariatric 
surgery. Black and colleagues (1992) examined 88 patients seeking vertical banded gastroplasty 
and found that 22.7% had a lifetime prevalence of an alcohol use disorder. The participants did 
not significantly differ from controls matched on age and gender, yet they were not matched on 
BMI.  Rates of drug use were even lower (2.3%) and were also not significantly different from 
controls.  In contrast, those seeking treatment were significantly more likely to have a lifetime 
prevalence of tobacco dependence (40.9% compared to 21.1%). Kalarchian and colleagues 
(2007) examined bariatric surgery candidates and found lifetime rates of 17.7% and 13.2% for 
alcohol abuse and dependence, respectively. However, 32.6% met criteria for lifetime rates of 
any substance disorder, although current rates of substance use were much lower: 1.7% with only 
.7% meeting criteria for alcohol dependence, and none for alcohol abuse. Interestingly, a more 
recent study (Mühlhans, Horbach, & Zwaan, 2009) identified even lower lifetime rates of 
substance use in bariatric candidates. A total of 15.1% of all participants had a lifetime rate of 
substance use disorders, while 11% met criteria for an alcohol use disorder. Current rates were 
much lower, with only one participant (N=146) meeting criteria for an alcohol use disorder 
(0.7%) and only one meeting drug use disorder criteria. Research from the National Comorbidity 
Survey finds that substance use disorders occur in roughly 14.6% of the general population; 
therefore it appears in general bariatric candidates present with a higher lifetime prevalence of 
substance use disorders compared to the general population (Kessler et al., 2009).  Of note is the 
discrepancy between studies conducted as part of the pre-surgical screening process and those 
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conducted independent of the process. Mühlhans, Horbac, and Zwaan (2009) highlight that 
higher rates of lifetime and current substance use are found in studies conducted independent of 
the surgical approval process, suggesting that underreporting of symptoms may occur in those 
afraid of not receiving surgery.   
Addiction Transfer 
Interestingly, a recent report (Ertelt, Mitchell, Lancaster, Crosby, Steffen, & Marion, 
2008), along with media attention and anecdotal evidence from substance abuse treatment 
providers, suggests elevated rates of alcohol use among post-bariatric patients. Media reports in 
particular have identified “addiction transfer” as a phenomenon that occurs among post-bariatric 
patients. While not a clinical or scientific term, “addiction transfer” refers to patients with 
addictive disorders who successfully overcome an addiction and subsequently develop another, 
thus transferring their addictive tendencies onto another form of addictive behavior. This theory 
implies that an underlying addictive pathology exists and causes the addictive behavior to 
manifest in a different form after successful treatment. Addiction transfer is similar to the 
concept of symptom substitution, which was a common debate during behavior therapy’s early 
emergence. The idea of symptom substitution was that mere treatment of overt symptoms, 
without addressing an underlying pathology, would lead to the emergence of a new symptom.  
This theory, however, was not supported by empirical evidence (Kazdin, 1982). Similar to 
symptom substitution, addiction transfer has not received any empirical support.  
While substance abuse is recognized as a chronically relapsing condition (Lescher, 1997), 
the temporal sequencing of engaging in alternate or substitute substance use remains unknown, 
given the lack of longitudinal studies. The age of onset for drug and alcohol dependence peaks 
around age 18 and rapidly declines after age 25 (Li, Hewitt, & Grant, 2004; Kessler et al., 2009) 
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yet it is unclear if patients who successfully overcome substance dependence develop a different 
or new addiction. Furthermore, data on whether recovered alcoholics transfer to excessive eating 
is also unknown. It is well known clinically, that patients who relapse typically relapse to their 
drug of choice, and yet it is unknown if addiction transfer occurs for typical substance users.  
With respect to obesity or excessive eating behavior, the term “addiction” is used to 
denote an addiction to food. Therefore, among post-bariatric patients, the treatment itself, or the 
surgical changes in anatomy, are hypothesized to cause the patient to develop a new addiction 
(e.g., alcohol use) due to the lack of treatment for the underlying problem. Although the 
explanation seems logical, “addiction transfer” among post-bariatric patients has been criticized 
due to the lack of empirical support (Sogg, 2007). However, if food is conceptualized as a post-
bariatric patient’s “drug,” the surgical constraints would not allow a post-bariatric patient to 
relapse to their drug of choice. This puts post-bariatric patients in a unique position, perhaps 
making a “transfer” more likely to occur, and perhaps particularly so if a patient also has a 
history of substance abuse. Given the high lifetime rates of substance dependence among 
bariatric candidates in combination with high rates of substance relapse, an examination of post-
bariatric substance use is warranted.  
Substance Use among Post-Bariatric Patients 
Few studies have directly examined substance behavior among post-bariatric patients 
(Ertelt et al., 2008; Odom et al., 2010). In one study, Odom and colleagues (2010) recently 
surveyed postoperative patients regarding their concerns about alcohol or substance use. They 
found concerns over substance or alcohol use independently predicted weight regain. 
Preoperative substance use was not assessed, however.  
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Ertelt and colleagues contacted post-bariatric patients by mail 6-10 years after their 
surgery, asking them to complete a Post-Bariatric Surgery Appearance Questionnaire (developed 
for the purpose of the study). The authors found that a small proportion of participants developed 
alcohol use problems after surgery. However, many limitations were present, including small 
sample size (e.g., N = 70) and a lack of matched controls. The report also had a relatively low 
response rate (28%) given the selection factors of examining a substance-using population; it is 
logical that substance-using post-bariatric patients would be less likely to participate in the 
questionnaire. Furthermore, although the study examined rates of alcohol dependence and abuse, 
there was no information regarding the time of symptom emergence, or the temporal sequencing 
of events. Nonetheless, based on DSM criteria, the study found that 8.6% of respondents met 
criteria for alcohol dependence post-surgery (N = 6), and one individual met criteria for alcohol 
abuse. Additionally, 5.7% met retrospective screening criteria for alcohol dependence before and 
maintained their diagnosis after surgery (N = 4), while one participant met retrospective criteria 
for alcohol abuse, which stayed consistent after surgery. Two individuals spontaneously 
developed alcohol dependence after their bariatric surgery, and these participants did not identify 
alcohol problems or symptoms before their surgery. 
Interestingly, although Ertlelt et al. conclude that low rates of substance use are identified 
in post-bariatric patients, they found that at least half of the participants surveyed (N = 38) 
endorsed that changes had occurred in their response to alcohol following their surgery. Of the 
38 participants, 24 of them believed they became intoxicated more rapidly, and 14 endorsed 
feeling intoxicated after drinking less alcohol. Not a single participant endorsed the belief that it 
took them longer to become intoxicated or that it took more alcohol than before their surgery to 
become intoxicated.  
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Experimental evidence has found that post-bariatric patients may have increased 
sensitivity to alcohol for two reasons: the reduction in body weight and the rapid absorption 
producing higher blood-alcohol concentration to create increased feelings of inebriation during 
and shortly after drinking (Klockhoff, Naslund, & Jones, 2002). Two experimental studies have 
examined this effect in post-bariatric patients. Klockhoff and colleagues (2002) identified a 
higher and faster absorption of alcohol among female post-gastric bypass patients compared to 
controls matched on gender, age, and BMI who had not received weight loss surgery; however, 
the blood alcohol content (BAC) only remained higher among the bypass patients for 30 minutes 
after dosing. The authors suggest that the change in absorption may be a result of the smaller 
stomach size and the faster transfer of fluids into the jejunum as a result of gastric emptying. A 
more recent study replicated this effect in men and women and found that post-gastric bypass 
patients reached a higher BAC, peaked more quickly, and took longer to return to 0 (i.e., 
baseline) than controls (Hagedorn, Encarnacion, Bratt, & Morton, 2007), suggesting that gastric 
bypass surgery may alter the way alcohol is metabolized in both male and female post-bariatric 
patients. The increased sensitivity to alcohol, creating quicker feelings of inebriation, may serve 
as a strong reinforcer in post-bariatric patients, thus contributing to an increased risk for 
developing alcohol problems. Given that the lifetime rates of substance use are high among 
bariatric candidates, these findings may be particularly salient for post-bariatric patients who 
may have experienced drug or alcohol problems in the past, increasing the tendency for relapse 
after surgery. 
Prevalence of Post-bariatric Patients enrolled in Substance Abuse Treatment 
In 2006, Brighton Hospital, a comprehensive substance abuse treatment facility, began 
observing increased admissions of patients who reported histories of bariatric surgery (Saules et 
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al., 2010). In an effort to estimate the prevalence of post-bariatric patients in substance abuse 
treatment, the hospital instituted procedures to better track this variable in the electronic medical 
record (EMR) upon admission. Of 7,199 patients admitted between 2006 and 2009, 54 patients 
were identified as having a history of bariatric surgery (0.8% of the full sample). This pattern 
increased over time, with significantly more cases in 2009 (2%) than in earlier years of tracking. 
Notably, however, the original tracking identified only 51 bariatric cases. However, upon review 
of their charts, 3 cases originally selected as matched-controls were also identified as post-
bariatric cases for the investigation. Therefore, roughly 6% of the randomly selected non-
bariatric cases were actually post-bariatric cases, but the data were not entered into EMR. 
Extrapolating to the entire patient population at this facility, these data suggest that the actual 
prevalence of bariatric surgery patients enrolled in substance abuse treatment programs may 
actually be much higher than 6%, given that 6% of the randomly selected non-bariatric sample 
were identified as bariatric cases. 
Chart reviews of the post-bariatric patients and matched-controls were conducted using a 
data tracking form developed to examine specific variables of interest. Charts were reviewed by 
one member of the research team, and a second member of the team reviewed the chart an 
additional time to scan for missing data the first reviewer was unable to identify. The 
investigation was conducted to generate future hypotheses, including hypotheses for the present 
investigation. 
 Saules et al. (2010) reported significant differences between the post-bariatric patients 
and non-bariatric cases. Post-bariatric patients were significantly more likely to be female, and 
although post-bariatric patients were equally likely to be diagnosed with alcohol dependence, 
they were significantly more likely be diagnosed with alcohol withdrawal.  
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Post-bariatric patients were found to have a significantly higher BMI than matched 
controls, but these groups did not differ on employment, marital status, race, depression anxiety, 
or substance abuse diagnostic categories. Post-bariatric patients were, however, less likely to be 
current smokers than controls.  
 
Figure 2. Alcohol Dependence and Withdrawal Diagnoses for Bariatric History Negative vs. 
Positive Substance Abuse Treatment Admission 
The majority of post-bariatric patients sought treatment primarily for alcohol (62.3%), 
with 9.4% for alcohol plus another drug, 13.2% for opiates, 7.5% for benzodiazepines, 5.7% for 
polysubstance abuse, and one participant sought treatment for amphetamines. This distribution 
was significantly different than for control cases. Controls had higher percentages of opiate and 
polysubstance use whereas post-bariatric patients had higher alcohol, alcohol plus another drug, 
and benzodiazepine rates.  
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Figure 3. Percentage of Patients Seeking Treatment by Substance Abuse Type for Bariatric 
History Negative vs. Positive Substance Abuse Treatment Admission 
When examining only the bariatric patients, a high proportion of patients (43.4%) were 
identified as initiating heavy substance use after their surgery, with no reported history of 
substance use before their surgery. Additionally, among the sample, 35.8% engaged in heavy use 
prior to their surgery, while 20.8% reported heavy use of one substance prior to surgery and 
began heavy use of another drug and/or alcohol after surgery. Among alcohol users, the majority 
(61.9%) engaged in heavy use prior to surgery, while this pattern was reversed for opiate 
(66.7%) and benzodiazepine users (89.5%), who initiated heavy use post-surgery.  
A further analysis of the Saules et al. data, including the addition of 22 newly enrolled 
patients (Wiedemann et al., 2010) found patients initiating substance use prior to surgery  
(defined as “relapsers”) were significantly more likely to use alcohol or marijuana after surgery, 
than patients with no reported history of substance use prior to surgery (defined as “new onset 
users”: NOU). Furthermore, using semi-structured interviews with 20 post-bariatric patients 
enrolled at Brighton Hospital, Ivezaj, and colleagues (2010) found that the majority of patients 
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sought treatment for substance abuse only 5 years after their surgery. Interestingly, in contrast, a 
qualitative analysis suggests that patients typically developed substance use problems a year 
following their surgery (see figure 2), with several participants developing problems immediately 
after surgery. 
  
 
 
 
 
 
 
 
 
A = Alcohol    D = Drugs P = Pain Medications  
X = Bariatric Surgery Red = Problematic Use 
Figure 4. Representative Sample (n = 14) of Trajectories of Substance Abuse Development 
Relative to Bariatric Surgery 
Self-reported alcohol consumption per day was typically identified in patient’s charts as a 
range (e.g., “a pint to a fifth of vodka per day”). To account for the range, a minimum and 
maximum number of standard drinks per drinking day were recorded. Most (83.3%), patients 
reported current drinking, yet not all patients were drinking daily. The percentage of post-
bariatric patients currently drinking did not significantly differ versus controls. Post-bariatric 
patients, however, reported a statistically higher minimum number of drinks per drinking day, 
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and this effect was more pronounced among those diagnosed with alcohol dependence (reporting 
a higher minimum and maximum number of drinks consumed per drinking day than controls).  
 
Figure 5. Maximum and Minimum Number of Standard Drinks per Day for Alcohol Dependent 
Patients 
The investigation by Saules and colleagues was the first to report the prevalence rate of 
post-bariatric patients currently enrolled in substance abuse treatment and suggests post-bariatric 
patients may be over-represented in drug and alcohol treatment centers. The most striking 
finding suggests although bariatric and non-bariatric patients were equally likely to be diagnosed 
with alcohol dependence, the post-bariatric patients were significantly more likely to be 
diagnosed with alcohol withdrawal and consumed larger quantities of alcohol per drinking day 
(i.e., the lower and upper limit for post-bariatric cases was 19-50 drinks per drinking day, while 
controls averaged 15-34 drinks per drinking day). This finding is especially striking given the 
experimental evidence which suggests post-bariatric patients reach higher blood alcohol level 
(BAL) than controls (Hagedorn et al., 2001; Klockhoff, Naslund, & Jones, 2002),  reach this 
level faster (Klockhoff, Naslund, & Jones, 2002), and take a longer time to return to baseline 
(Hagedorn et al., 2001).  
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Rationale for Present Study  
The current evidence suggests there are significant differences in post-bariatric patients’ 
substance use compared to non-bariatric substance use treatment seekers yet clearly more 
evidence is warranted to understand this phenomenon. It is unknown if post-bariatric patients in 
substance abuse treatment have unique treatment needs or whether unique variables may affect 
the course or prognosis of their substance use. Additionally, if post-bariatric patients are at risk 
for developing substance abuse, etiological factors should be identified and targeted during 
surgical preoperative evaluations or early post-operative assessments.  
A more systematic replication of the findings by Saules and colleagues is warranted, 
given that several limitations present in their investigation. At times, patients’ charts exhibited 
conflicting findings. For instance, a chart might note a patient was a smoker, and another record 
might report he or she was a non-smoker. In such cases, the default assumption was that the 
variable was present, but a more systematic approach to data collection would have been 
desirable. Additionally, information collected may have been influenced by the perceptions or 
biases of healthcare providers.  Finally, there is some possibility of threats to validity as a result 
of circumstances surrounding the original collection of data later examined by this study in chart 
review.  Specifically, a substantial amount of the data was collected upon intake to the hospital, 
at a time when patients would be expected to be in a state of active substance use and perhaps 
acute distress.  Some evidence suggests that patients initially admitted for substance abuse 
treatment, as a result of this highly distressed presentation, may be more vulnerable to 
misdiagnosis.  One study, for instance, found that these patients were frequently misdiagnosed 
with bipolar disorder due to the similarity between bipolar symptoms and those of active 
substance use (Goldberg, Garno, Callahan, Kearns, Kerner, & Ackerman, 2008).  Systematic 
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data collection from patients currently enrolled and stabilized in treatment may provide a more 
reliable assessment of the patient’s perceptions, history, and other variables that may be salient in 
meeting the needs of post-bariatric patients enrolled in substance abuse treatment programs.   
Method 
In February, 2009, this study received approval from the institutional human subjects review 
board at Eastern Michigan University and Providence Hospital and Medical Centers IRB to 
ensure safety and protection of the participants. Data collection was conducted from July 2009 
till April 2011. All patients enrolled received an informed consent, which explained participants’ 
rights, possible distress for participating, and the voluntary nature of the study. 
Participants 
A total of 57 post-bariatric patients, and 60 control (i.e., non-bariatric) substance abuse 
treatment patients were recruited for the purpose of this investigation. All participants were 
current patients who were voluntarily enrolled and are receiving treatment in Brighton Hospital’s 
detoxification and rehabilitation programs. Brighton Hospital is the second oldest comprehensive 
drug and alcohol treatment program in the United States and receives patient referrals from a 
broad geographic range including Southeastern Michigan, Chicago, Indianapolis, Cincinnati, and 
Columbus OH (see http://brightonhospital.org/ for more information about the hospital and its 
various programs). All patients who reported receiving bariatric surgery were identified by staff 
members and asked to enroll in the study. An additional sample of 13 female control cases was 
also recruited in order to match participants for the number of drinks per day hypothesis (see 
below: hypothesis 2b). 
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Procedure 
 Members of Brighton Hospital’s staff routinely assessed all patients currently enrolled in 
Brighton’s rehabilitation, detoxification, or partial hospitalization programs from 7/02/2009 until 
4/01/2011. History of bariatric surgery was routinely assessed at intake. If patients reported a 
history of weight loss surgery, they were asked to voluntarily participate in a research study. If 
they agreed, a member of Brighton Hospital’s medical records personnel scheduled a meeting 
with a member of the research team to conduct a semi-structured interview. Recruitment was 
also conducted by a series of fliers posted throughout the facility and by staff who encountered 
patients who later reported receiving surgery. In order to recruit control participants, research 
staff were made available three days a week, at various scheduled times, and a series of 
announcements were made offering all patients the opportunity to participate. Research staff 
obtained informed consent from the patients and distributed the questionnaires.  The patients 
later returned questionnaires to the research team or Brighton Hospital staff members.  
Measures 
 The data analyzed for this investigation includes patient’s EMR, chart review data, self-
report questionnaire data and semi-structured interviews, the latter of which were only conducted 
with the post-bariatric patients as part of a larger study.  
EMR. The data analyzed for hypothesis 2a includes data received from patients EMR.  
This database included all treatment seeking patients at Brighton Hospital from July 2009 to 
April 2011. This database included all relevant ICD-10 diagnoses (e.g., substance use disorders) 
and a field was added to track history of bariatric surgery.  
Chart Review Data. A data tracking form was constructed to record all necessary 
information obtained from chart review forms. The variables of interest include: demographic 
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information, history of bariatric surgery, health information (e.g., height and weight, history of 
type II diabetes, hypertension), diagnoses, primary reason for treatment, history of sexual, 
physical or emotional abuse, smoking status (i.e., current, never, ex-smoker; if current, number 
of cigarettes per day), age of regular drug or alcohol use, age of first use and age of heavy use for 
each drug used, a report of all drugs ever used,  and the minimum and maximum number of 
drinks per drinking day. During preliminary data collection, we identified a significant range in 
the number of drinks consumed per drinking day, as reported in patients’ charts. Therefore, to 
account for this variability, we constructed variables called minimum and maximum of drinks 
per drinking day. A standard drink was defined as a 12oz can of beer, a 5oz glass of wine, and 
1.5oz of hard liquor. If a chart indicated a variable was both present and absent, our default 
assumption was that it was indeed present. Any ambiguities were resolved by team consensus so 
that future decisions were made consistently and systematically by all chart reviewers.   
Survey. All participants were asked to complete a survey assessing demographics, 
weight-related history, substance use (AUDIT-R; Fleming & Barry, 1990), quality of life 
(WHOQOL-BREF; Murphy, Herrman, Hawthorne, Pizone, & Evert, 2000), and behavioral 
excess.  
Demographics. Information was obtained on a variety of demographic variables 
including age, gender, BMI (self-report of participants height and weight), race/ethnicity (self-
report of participants ethnic background), years of education completed, relationship status (i.e., 
married, living with partner (same sex), living with partner (opposite sex), single (never 
married), divorced, remarried, widowed, separated, other), employment status (working full time 
greater than 35 hours per week, part-time regular hours, part-time irregular hours, unemployed-
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student, unemployed-homemaker, unemployed-other, retired, disability, military), 
socioeconomic status (SES), and income.  
Weight-related health history. Given that medical complications and comorbidities are 
common among the bariatric population, 10 items were constructed to assess weight-related 
health history. These items were meant to capture the timing and associated variables of surgery. 
Examples include, “What type of weight loss (bariatric) surgery have you had”, “Were there any 
surgical complications” and “How old were you when you had bariatric surgery?” These items 
include a closed and open-ended response option and were only given to the post-bariatric 
patients. Additionally, all patients were assessed for several medical comorbidities commonly 
associated with obesity, such as type II Diabetes  
Alcohol Use Disorders Identification Test (AUDIT-R; Fleming & Barry, 1990). The 
AUDIT-R is a 10-item measure designed to assess alcohol and substance use disorders. The 
original measure solely assessed alcohol use disorders (Babor, Fuente, Saunders, & Grant, 1992). 
The AUDIT-R is a modified version which includes other drugs (i.e., cocaine/crack, other 
stimulants, heroin or other opiates, marijuana, tranquilizers, hallucinogens) in order to assess a 
range of drug use. For instance, one modified item includes “How often would you have 6 or 
more drinks per day, 1 or more joints/lines/rocks/doses per day, or 3 or more pills per day.” The 
first two items assess frequency and amount of use. All questions are scored by a 5-point Likert 
scale and responses range from not at all, monthly, weekly, several times/week, daily moderate 
use, daily heavy use. Number of doses of a substance per day provided response options of none, 
1-2, 3-4, 5-6, 7-9, 10 or more. Scores range from 0 to 40, with higher scores reflecting more 
hazardous and severe drug or alcohol use. The original measure of the AUDIT has been 
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extensively researched and demonstrated high internal consistency and good test-retest reliability 
(see Reinert & Allen, 2007 for a review).  
Substance use trajectories. Items were created by the authors to assess age of regular 
use, concern about use, and age when participant first sought treatment for drug and alcohol use. 
Examples include: “How old were you when you first began to regularly use alcohol?” and 
“When did you or others first become concerned about your alcohol/drug use?” Regular use was 
defined as two or more times per week. These items were included to better characterize the 
temporal sequencing of drug and alcohol problems participants were experiencing.  
World Health Organization Quality of Life—BREF (WHOQOL; Murphy, 
Herrman, Hawthorne, Pinzone, & Evert, 2000). The WHOQOL-BREF assesses quality of life 
across four various domains: physical health, psychological health, social relationships, and 
environment. This 26-item measure is a shorter version of the original instrument (WHOQOL-
100). Examples of these items include:  “To what extent do you feel that (physical pain) prevents 
you from doing what you need to do?” and “Do you enjoy your life?” These items are scored on 
a 5-point scale ranging from 1 indicating “Not at all” to 5 “Very good.” Items 4 and 26 are 
reverse-scored. Scores on this measure range from 26 to 130, with higher scores indicative of a 
better self-reported quality of life. Reliability for this measure was established based on internal 
consistency for the full scale (α = .84) and across each of the four domains (α = .80: physical 
health, .76: psychological health, .66: social relationships and .80: environment) (Aigner, 
Forster-Streffleur, Prause, Freidl, Weiss, & Bach, 2006). The test-retest reliability for the full 
scale (.76) and across four domains (.66 to .87) over a two to eight week period was also 
generally high (Murphy et al., 2000). Correlations between scores on the WHOQOL-100 and 
WHOQOL-BREF were high (r = .89 to .95). The WHOQOL-BREF shows good discriminant 
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validity between healthy and sick individuals as well (Murphy et al., 2000). A factor analysis 
confirmed the fit of the four domain model to the WHOQOL-BREF. Results indicate the 
physical health domain loads most heavily on the global quality of life, while the social domain 
loads the least (Murphy et al., 2000). 
Behavioral Excesses. This investigation sought to explore whether other excessive 
behavioral tendencies (e.g., gambling) co-occur with post-bariatric surgery patients in substance 
abuse treatment. Therefore, a 7-item measure was constructed to capture the range of “behavioral 
excess.” The measure asks: “During the four weeks before you came to Brighton, how often 
were you participating in each of the following activities” and answers include: internet surfing, 
gambling, videogame playing, sexual behavior outside of a committed relationship, eating sweets 
in amounts that most people would consider excessive, eating carbohydrates in amounts that 
most people would consider excessive, eating large amounts of food very late at night. 
Responses range from “Not at all” to “Nearly everyday, indicating 1 to 4, respectively. No items 
are reversed scored and scores range from 0 to 28, with higher scores reflecting greater 
behavioral excess. There are no established psychometric properties, as this measure was 
constructed solely for this exploratory phase of this investigation. This investigation will only 
focus on the following categories: internet surfing, gambling, videogame playing, and sexual 
behavior outside of a committed relationship, and compare frequency of behavior by comparing 
those who engage in several days or more, to those who report “not at all.”  
Semi-structured Interview. Post-bariatric participants also participated in a brief (i.e., 
30 to 60 minute) semi-structured interview, as part of a larger investigation. The interview was 
designed by the current investigators in an effort to understand the pre-surgical screening process 
(e.g., what type of assessments the patient received, if alcohol use was systematically assessed in 
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the pre-surgical screening) before the bariatric surgery, in addition to examining factors and 
events that occurred after the surgery (see Appendix E for a copy of the full interview). 
Participants were asked about the relationship between eating behavior and alcohol/drug use: 
“are they connected in any way”, “is one a substitute for another”, or “do you think they are 
unrelated types of problems”, and asked how they formed their impression. Participants were 
asked about their thoughts and impressions about why they encountered problems with drug or 
alcohol, and if they had any ideas of what might help post-bariatric patients avoid problems with 
drugs or alcohol. A member of the research team wrote the participant’s responses verbatim 
during the interview; after the interview the research staff typed the patient’s responses, 
including original quotations. The material was then coded to identify themes that emerged, as 
part of a larger investigation.  For the purposes of the present report, the interview data were 
used to verify any inconsistencies between survey and chart review data, and permit a more valid 
classification of “relapse” versus “new onset” status. Given that our research team’s preliminary 
findings revealed that a substantial number of patients report initiating heavy substance use after 
surgery (i.e., 43.4% Saules et al., 2010), it was anticipated that roughly half of patients would be 
classified what we define as “new onset users” (NOU). Participants were classified as 
“Relapsers” if they reported any history of regular substance use prior to their weight loss 
surgery. For example, a participant seeking treatment for cocaine abuse but reported a history of 
alcohol abuse prior to surgery, would be classified as a “relapser,” whereas a patient who 
reported the spontaneous development of benzodiazepine abuse after surgery and no abuse of 
substances prior to weight loss surgery would be classified as a “new onset user.”  The 
classification of NOU and Relapser status was obtained from two variables—a question asked 
during the semi-structured interview which asks: “Do you feel like your problems with 
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alcohol/drugs began AFTER you had bariatric surgery?  If yes, please describe how you began or 
increased your use of alcohol/drugs, and how you became concerned that it might be a problem 
for you,” in addition to the substance use trajectory item in the questionnaires, which asks for the 
patients age at when they first engaged in regular substance use. 
Specific Aims 
The proposed investigation sought to replicate the previous findings from Saules and 
colleagues (2010), as well as incorporate and extend the pilot data from Izevaj et al. (2010) and 
Wiedemann et al. (2010). Given the finding that post-bariatric patients quickly develop 
problematic substance use after surgery, better characterization of the timing of substance 
development and how it may differ from non-bariatric patients is warranted (Hypothesis 1). 
Additionally, this investigation sought to understand associated features (e.g., type of substance 
use and frequency of substance use (Hypotheses 2a-2c), quality of life (Hypothesis 3)) of post-
bariatric patients in substance abuse treatment, and how they may differ from non-bariatric 
substance-using patients. This investigation also sought to examine whether or not post-bariatric 
patients are more likely to engage in other forms of behavioral excess (e.g., gambling, excessive 
internet use) than controls, thus providing support for the theory of addiction transfer 
(Hypothesis 4). Last, the present study sought to examine etiological factors of spontaneous 
development (i.e., NOU) of substance dependence, post-surgery, or unique features of NOU 
status. 
Hypotheses and Data Analyses 
The data was analyzed using SPSS version 17.0 statistical software.  
Hypothesis 1: Latency. Consistent with observations from qualitative interviews 
conducted with patients during the first wave of this study (Ivezaj et al., 2010), it was 
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hypothesized that post-bariatric patients would experience a shorter latencies between age of 
regular substance use, age when concerned about substance use, and age when the patient first 
sought treatment for substance abuse than patients who have not received weight loss surgery. 
This hypothesis was tested by conducting a t-test to examine group differences. Latency was 
examined by comparing the mean differences in time of post-bariatric patients and controls by 
examining three different ages: age of regular substance use, age when concerned about 
substance use and age when patient first sought treatment.  
Hypothesis 2a: Alcohol withdrawal. It was hypothesized post-bariatric patients would 
be more likely to experience alcohol withdrawal. This hypothesis is consistent with this research 
team’s previous findings which suggest post-bariatric patients were significantly more likely to 
be diagnosed with alcohol withdrawal than non-bariatric patients (Saules et al., 2010). A chi-
square analysis was used to compare the groups and these data were exported from electronic 
medical records. 
Hypothesis 2b: Number of drinks consumed. It was hypothesized that post-bariatric 
patients would consume a greater minimum and maximum quantity of drinks per day. This 
hypothesis was based on our research team’s original findings which suggested that post-
bariatric patients consume a greater maximum quantity of drinks per day than non-bariatric cases 
(Saules et al., 2010). For the purposes of this hypothesis, the participants with chart review data 
for self-reported minimum and maximum number of drinks per drinking day were included in 
this analysis.  Given that there were significant differences between bariatric patients and 
controls on gender, and that there are well documented gender differences in alcohol intake, with 
women drinking less than men on average, (Nolen-Hoeksema, 2004; Wilsnack, Vogeltanz, 
Wilsnack, & Harris, 2000) bariatric patients with reported alcohol use (n = 45) were matched on 
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gender.  For testing this hypothesis only, Control participants were oversampled to yield enough 
female participants for matching (oversampled females n = 13).  Then, the forty-five alcohol-
using bariatric patients were matched with forty five control participants.  Patients who provided 
a minimum and maximum number of drinks per day and who were diagnosed with alcohol 
dependence or withdrawal were selected for this analysis.  A t-test was conducted to examine 
group differences.  
 Hypothesis 2c: Total number of substances. It was hypothesized that post-bariatric 
patients would use significantly fewer substances than patients who had not received weight loss 
surgery. This was also an attempt to replicate our research’s team previous findings suggesting 
that post-bariatric patients tend to use alcohol and opiates, while control subjects report using 
multiple and a variety of other substances.  The following substance categories were assessed: 
alcohol, cocaine/crack, other stimulants (Ritalin, Amphetamine, Adderall, Methaetamine, ect.), 
Heroin or other opiates, Tranquilizers (Xanax, Klonopin, Valium, GHB, Roofies, ect.), and 
Hallucinogens (LSD, Esctasy, Mushrooms, Ketamine) for a total of 7 substance categories that 
were compared.  A t-test was conducted to explore group differences. This data was obtained 
from the AUDIT-R self-reported substance used. 
Hypothesis 3: Quality of life. It was hypothesized that post-bariatric patients would 
endorse a poorer quality of life than patients who have not received weight loss surgery based on 
evidence that bariatric candidates experience a significantly poor quality of life.  An ANOVA 
was used to examine group differences on the four domains of QOL: physical, psychological, 
social, and environmental.   
 Hypothesis 4: Behavioral excess. The behavioral excess questions were originally 
included based on the addiction transfer theory which suggests that those who abstain from 
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excessive food intake may “transfer” their addictive behavior to another addiction thus replacing 
their “food addiction.” Therefore, it was hypothesized that post-bariatric patients would endorse 
greater behavioral excess (e.g., gambling, excessive sexual behavior, video game play, internet 
use) than patients who have not received weight loss surgery. Each excessive behavior was 
examined separately, and tested categorically. The responses range from not at all, several days a 
week, more than half of the days, to nearly every day, therefore the response were dichotomized 
comparing, not at all (no), with several days a week to nearly every day (yes). A chi-square 
analysis was used to examine group differences. 
 Hypothesis 5: Exploratory analyses. Of the total post-bariatric sample that was 
recruited, 39.3% (n=22) were classified as Relapsers and 60.7% (n=34) were classified as NOUs.  
The proposed exploratory hypotheses sought to examine differences between these two sub-
groups, yet given that the total responses for the questionnaires among Relapsers was low 
(n=19), statistical power was weak.  However, several significant differences emerged when 
examining these groups, therefore, all of the proposed hypotheses will be replicated (i.e., 
hypothesis 1, 2b, 2c, 3 and 4) by comparing Relapsers and NOUs as the comparison group at the 
end of each section.  It was hypothesized that Relapsers would be significantly more likely to 
engage in multiple substance use (e.g., alcohol and opiates), whereas NOUs would report less 
overall substance use.  
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Results 
Participants 
 
 
 
 
 
 
 
 
 
 
 
 All participants were current male and female patients who were voluntarily enrolled in 
Brighton Hospital's detoxification, residential, and partial hospitalization programs.  A total of 57 
post-bariatric and 60 control (i.e., non-bariatric) substance abuse treatment patients were 
recruited.  Initially, 83 control cases consented to participate, yet only 60 completed and 
provided questionnaire data, yielding a 72.29% rate of return.  A total of 57 post-bariatric 
patients provided informed consent and participated in the interview portion of the study, but 
only 51 submitted questionnaire data, yielding an 89.47% full completion rate by post-bariatric 
patients.  Therefore, for 5 of the bariatric participants, data are missing for the following 
variables: binge eating and associated symptoms, quality of life, depression and anxiety, 
smoking, alcohol and drug use, behavioral excesses.  Several demographic variables that were 
Total Sample (N= 4,658) 
Excluded  (n= 1) 
   Not meeting inclusion criteria 
Post-bariatric sample (n= 56) Controls (n=73) 
Total recruited sample  
(n= 130) 
NOUs 
(n= 34) 
Relapser 
(n= 22) 
Proposed control 
cases 
(n= 60) 
Over recruited female 
participants for hypothesis 
2b 
(n= 13) 
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missing from the 5 patient’s questionnaire data that could clearly be obtained from the patient’s 
chart reviews (i.e., gender, race, age, height and weight, amount of weight lost from surgery) 
were retrieved and included in the final analyses.  One post-bariatric patient received bariatric 
surgery for non-obesity related reasons, and therefore was excluded from the final analyses.  
Post-bariatric Prevalence 
During the duration of the study enrollment period (i.e., July 2009 to April 2011), a total 
of 4,658 patients were admitted to Brighton Hospital, 118 of whom received an ICD-10 
diagnosis code of V45.86 for Status Post Bariatric Bypass in the electronic medical record.  This 
yields a prevalence rate of 2.5% of all admissions with a recorded diagnosis of having received 
bariatric surgery.  However, an additional 11 patients volunteered to be interviewed, whereupon 
both their self reports and the chart narrative supported that they had bariatric surgery, yielding a 
full sample of at least 129 bariatric patients, for a more accurate estimate of 2.8% of admissions 
with such a history.  Notably, however, this is probably still an underestimate:  if 11 of 56 
bariatric cases (i.e., 19.6%) were not identified in the EMR, then roughly 20% of all true cases 
may have been missed.  In addition, data from repeat admissions bolsters this conclusion.  That 
is, among those bariatric cases with multiple admissions (n=49), 65.3% did not have a bariatric 
diagnosis entered in the EMR for all treatment episodes.  
  Of the 129 bariatric surgery patients identified (either from the EMR or by patients 
simply volunteering when they learned about the study), 56 were recruited and met criteria for 
the final study, yielding a 43.4% recruitment rate.   
Of the post-bariatric sample (n=56), 91.1% identified as White, 3.6% were Black, 3.6% 
were “other” and 1.8% identified as Middle Eastern. Participants were 71.4% female, with a 
mean age of 44.80 years (SD= 9.49) and a current BMI of 31.18 (SD = 7.11). BMI did not 
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significantly differ by gender or racial status.  The majority of patients received Roux-en-Y 
surgery (90.6%) while 3.8% received Bilipancreatic diversion with duodenal switch, one patient 
received the Lap-Band adjustable gastric banding, one patient received the vertical banded 
gastroplasty, and one received the gastric sleeve.  Demographic variables of post-bariatric and 
control participants are summarized in Table 3. Additionally, significant differences emerged 
when comparing Relapsers and NOUs (see Table 5).  
Table 3 
Sample characteristics of post-bariatric patients versus controls
ab
 
Demographic Variables Post-Bariatric 
(n=56) 
Controls (n=60) Significance 
Gender (% female) 40 (71.4%) 23 (38.3%) ** 
Race (% white) 51 (91.1%) 51 (85%) ns 
Age 44.8 ±9.49 41.57 ±13.61 ns 
Education (yrs) 14.39 ±2.1 13.79 ±2.12 ns 
BMI 31.18 ±7.11 25.31 ±4.55 ** 
Marital status   * 
Married or living with partner 33 (62.5%) 16 (26.7%)  
Single 9 (16.07%) 16 (26.7%)  
Divorced or Separated 8 (14.29%) 19 (31.67%)  
Widowed 3 (5.4%) 2 (3.33%)  
Other 1 (1.8%) 0 (0%)  
Employment status   ns 
Working full time (>35 
hours/week) 
20 (36.4%) 15 (26.8%)  
Economic status   ns 
Barely enough to get by 9 (17.6%) 12 (22.2%)  
Enough, but no more 18 (35.3%) 13 (24.1%)  
Solidly middle class 14 (27.5%) 15 (27.8%)  
Plenty of extras 6 (11.8%) 8 (14.8%)  
“Luxuries” 2 (3.9%) 2 (3.7%)  
Don’t know/unsure/prefer not to 
say 
2 (3.9%) 4 (7.4%)  
Annual household income   ns 
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>150 thousand 5 (10%) 4 (7.8%)  
100-149 thousand  7 (14%) 8 (15.7%)  
75-99 thousand 3 (6%) 6 (11.8%)  
50-74 thousand 17 (34%) 9 (17.6%)  
25-49 thousand 10 (20%) 5 (9.8%)  
10-24 thousand 3 (6%) 8 (15.7%)  
<9 thousand  2 (4%) 2 (3.9%)  
Don’t know/unsure/prefer not to 
say 
3 (6%) 9 (17.6%)  
* = p < .05, ** = p < .01  
a
Values are expressed as n(%) or M±SD. 
b
N=116 except for employment (n=111), economic 
status (n=105) and income (n=101).  
 
Several follow up analyses were conducted to evaluate group differences in pre-treatment 
substances used, eating behavior, and psychological factors.  Controls were significantly more 
likely to report ever smoking, smoking in the last month, reporting current cocaine and marijuana 
use, while post-bariatric patients were significantly more likely to report a history of sexual 
abuse. These data are summarized in Table 4.  
Table 4 
Substance-related and psychological characteristics of post-bariatric patients and controls
ab
 
Follow-up Variables Post-Bariatric 
 (n=51) 
Controls (n=59) Significance 
Smoke ever 31 (60.8%) 47 (79.7%) * 
Smoke in the last month 23 (53.5%) 39 (72.2%) * 
Alcohol use (current) 39 (76.5%) 45 (80.4%) ns 
Cocaine use (current) 2 (4.2%) 11 (20.4%) * 
Stimulants (current) 4 (8.3%) 6 (11.1%) ns 
Heroin or opiate use (current) 22 (44%) 27 (50%) ns 
Marijuana use (current) 10 (20.4%) 20 (37%) * 
Tranquilizer use (current) 26 (53.1%) 22 (40.7%) ns 
Hallucinogen use (current) 0 (0%) 4 (7.5%) ns 
AUDIT alcohol score  29.69 ±8.71 27.5 ±10.36 ns 
AUDIT drug score 25.57 ±12.05 26.26 ±10.37 ns 
FTND total 6.09 ±2.11 5.40 ±2.07 ns 
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Anxiety total 12.46 ±6 11.09 ±6.6 ns 
Depression total 14.84 ±6.24 12.43 ±7.34 ns 
Physical abuse 16 (50%) 13 (31.7%) ns 
Emotional abuse 15 (51.7%) 16 (38.1%) ns 
Sexual abuse  19 (51.4%) 11 (25%) * 
* = p < .05  
a
Values are expressed as n(%) or M±SD. 
b
N=110 except for the following variables: smoke past 
month (n=97), alcohol use (n=107), cocaine (n=102), other stimulants (n=102), heroin/opiates 
(n=104), marijuana (n=103), tranquilizer (n=103), hallucinogen (n=103), FTND (n=61; i.e., 
current smokers only), AUDIT alcohol (n=79), AUDIT drug (n=66), anxiety (n=102), depression 
(n=103), physical abuse (n=73), emotional abuse (n=71), sexual abuse (n=81) 
 
Table 5 
Substance-related and eating behavior characteristics of Relapsers and NOUs
ab
 
Eating and Substance Variables Relapsers (n=19) NOUs (n=32) Significance 
Pre-operative binge eating  14 (73.7%) 13 (40.6%) * 
Pre-operative binge eating + loss of 
control over eating 
12 (85.7%) 12 (85.7%) ns 
Binge Eating Disorder 11 (57.9%) 9 (28.1%) * 
Smoke ever 15 (78.9%) 16 (50%) * 
Smoke in the last month 10 (58.8%) 13 (50%) ns 
Alcohol use (current) 16 (84.2%) 23 (71.9%) ns 
Cocaine use (current) 1 (5.6%) 1 (3.3%) ns 
Stimulants (current) 2 (12.5%) 2 (6.3%) ns 
Heroin or opiate use (current) 10 (52.6%) 12 (38.7%) ns 
Marijuana use (current) 7 (41.2%) 3 (9.4%) * 
Tranquilizer use (current) 13 (72.2%) 13 (41.9%) * 
Hallucinogen use (current) 0 (0%) 0 (0%) ns 
AUDIT alcohol score 29.58 ±7.65 29.74 ±9.38 ns 
AUDIT drug score 25.69 ±13.39 25.47 ±11.22 ns 
FTND score 6.0 ±2.65 6.15 ±1.73 ns 
* = p < .05  
a
Values are expressed as n(%) or M±SD. 
b
N=51 except for the following variables: loss of 
control (n=28), smoked last month (n=43), cocaine (n=48), other stimulants (n=48), 
heroin/opiates (n=50), marijuana (n=49), tranquilizer (n=49), hallucinogen (n=50), FTND 
(n=23), AUDIT alcohol (n=35), AUDIT drug (n=28) 
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Hypothesis I: Latency.  
Hypothesis 1 was partially supported given that there were significant differences in the 
age that post-bariatric patients engaged in substance use and quickly attended treatment after 
acknowledging concerns, yet did not differ in the time from regular substance use to treatment 
seeking age, and the age at which they began to regularly use substances and developed 
concerns. Three independent sample t-tests were conducted to compare post-bariatric patients 
and controls on the mean difference in duration of time (in years) in three variables: age when 
engaged in regular drug/alcohol use, age when self or others became concerned about 
drug/alcohol use, and age when first sought treatment.  Post-bariatric patients reported first using 
drugs (29.64 years, SD = 11.85 vs. 19.71, SD = 9.15) and/or alcohol (29.31 years, SD = 13.48 vs. 
18.39, SD = 6.57) regularly at significantly later ages than controls, t (95) = 5.148, p < .001 
(alcohol), t (73) = 4.093, p < .05 (drugs).  On average, post-bariatric patients also first became 
concerned about their alcohol/drug use (39.18 years, SD = 11.89 vs. 26.93, SD = 12.14) at a 
significantly later age, t (103) = 4.784, p < .001, and first entered drug/alcohol treatment (41.87 
years, SD = 10.21 vs. 33.55, SD = 13.70) at a later age than controls, t (105) = 3.531, p < .001.  
However, the first part of this hypothesis was not supported; the latency between regular use and 
concern about use did not significantly differ between post-bariatric patients and controls, t (102) 
= .66, p = .511, nor did the duration from regular use to age of treatment seeking t (104) = -.65, p 
= .517.  As hypothesized, however, post-bariatric patients did report a shorter latency from age 
of concern to age of treatment seeking t (103) = -2.197, p < .05 (see Figure 5). 
 While NOU’s reported a significantly later age of concern (41.35, SD = 9.94 vs. 32.72, 
SD = 13.23) when compared to Relapsers, t (49) = -1.72, p < .05, there were no differences on 
  
54 
any other age or latency variables.  Follow-up descriptive analyses were conducted to examine 
the mean age of concern, relative to age at the time of bariatric surgery.  On average, post-
bariatric patients reported it took them 1.6 years (SD = 1.62) after their bariatric surgery to 
become concerned about their drug and/or alcohol problem.  Interestingly, among Relapsers, the 
average time sober prior to their surgery was 9.18 years (SD = 8.37) with 64.3% of Relapsers 
reporting no substance use 5 years or more prior to surgery.  These analyses were replicated 
within the total sample to explore the potential effects of gender, by comparing men and women 
and were also examined within only the control group and results yielded no significant 
differences.  
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Figure 6. Latency between regular substance use, concern about substance use, and age of first 
treatment episode 
Note. N = 104, N = 105, N = 106, respectively. *p < .05.  
 
Hypothesis 2a: Alcohol Withdrawal 
It was expected that post-bariatric patients would be more likely to be diagnosed with 
alcohol withdrawal compared to the total treatment sample.  Consistent with the prior report by 
Saules et al. (2010), post-bariatric patients were compared to all non-bariatric patients at 
  
55 
Brighton Hospital in alcohol withdrawal diagnosis; data were obtained from electronic medical 
records of all patients admitted during the time of this study. A 2 X 2 (Bariatric status X Alcohol 
Withdrawal Diagnosis Yes/No) chi-square analysis was conducted.  As hypothesized, results 
indicate that post-bariatric patients were significantly more likely to be diagnosed with alcohol 
withdrawal: 55.9% of bariatric patients were diagnosed with alcohol withdrawal while only 29% 
of the non-bariatric sample was diagnosed as such χ2 (1, N = 4658) = 31.78, p < .001.  Post-
bariatric patients were also compared with controls on alcohol dependence and significant 
differences emerged.  Specifically, 68.8% of post-bariatric patients were diagnosed with alcohol 
dependence, while only 54.6% of controls were so diagnosed χ2 (1, N = 4658) = 7.41, p < .01.   
Hypothesis 2b: Number of Drinks Consumed.  
Contrary to this hypothesis there was no significant difference for the minimum number 
of drinks per drinking day.  There was a trend suggesting that bariatric patients may consume a 
greater maximum number of drinks per drinking day (p = .073), with bariatric patients reporting 
an average maximum number of 19.05 (SD = 11.01) and controls reporting 15.26 (SD = 8.66) 
drinks per drinking day.  
Additionally, no significant differences were observed between Relapsers and NOUs on 
the minimum or maximum number of drinks per day (p = .117, for both); Relapsers reported a 
mean number of 15.97 (SD = 11.85) minimum drinks per drinks per drinking day, and 22.51 (SD 
= 12.13) total maximum drinks per drinking day, NOUs reported a mean number of 11.81 (SD = 
6.11) minimum drinks per drinking day and 16.94 (SD = 10.10) maximum drinks per drinking 
day.  Statistical power for this analysis was weak, however, with alcohol use data only retrieved 
from 17 Relapsers and 27 NOUs. 
Hypothesis 2c: Number of Total Substances.  
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It was expected that control participants would be use significantly more substances that 
post-bariatric patients, however, the current findings did not find support for this hypothesis.  An 
independent samples t-test was conducted to compare post-bariatric patients and controls on the 
total number of substances used.  Contrary to expectation that control participants would engage 
in greater variety of substance use than post-bariatric participants, results indicated that post-
bariatric cases and controls did not differ on the total number of substance used t (105) = -1.246, 
p = .215.  Interestingly, however, significant differences were found between Relapsers and 
NOUs.  Relapsers reported using significantly more substances than NOUs, t (49) = 2.336, p < 
.05 
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Figure 7. Total number of substances used 
Note. N = 51, n = 19, n= 32, for Relapsers and NOU’s, respectively. *p < .05.  
 
Hypothesis 3: Quality of Life.  
It was expected that post-bariatric patients and controls would differ on the four domains 
of quality of life; physical health, psychological, social and environmental.  Therefore a one-way 
ANOVA was conducted to explore differences on mean scores in each domain.  This hypothesis 
was partially supported; post-bariatric patients reported significantly poorer psychological 
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quality of life, t (105) = -2.551, p < .05, yet did not differ on the other three domains, t (105) = -
.972, p = .333 (physical health), t (105) = -1.092, p = .277 (social), t (105) = -.037, p = .971 
(environmental).  To ensure the relationship between psychological quality of life and bariatric 
status was not solely a function of gender or BMI differences between groups, bivariate 
correlations were inspected; neither variable was significantly associated with quality of life.  
Furthermore, there were no significant differences on the stand-alone items which assess general 
QOL, t (105) = -1.288, p = .502, or and general health, t (105) = -1.140, p = .257.  
Within the psychological QOL domain, however, there were significant differences when 
examining the individual items. Post-bariatric patients reported significantly poorer QOL scores 
on each of the following items: “How much do you enjoy life?’, t (105) = -2.12, p < .05; “Are 
you able to accept your bodily appearance?”, t (105) = -2.06, p < .05; “How satisfied are you 
with yourself?”, t (105) = -2.20, p < .05; and “How often do you have negative feeling such as 
blue mood, anxiety, or depression?”, t (104) = -2.25, p < .05.  
No significant differences were observed between Relapsers and NOUs on any of the 
QOL variables. 
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Figure 8. Differences in quality of life in bariatric cases versus controls 
Note. N=107. *p < .05 
 
Hypothesis 4: Behavioral Excess.  
It was expected that post-bariatric patients would endorse other excessive behaviors yet 
this hypothesis was not supported.  Excessive internet use was reported by 38% of post-bariatric 
participants, and 50.9% of controls, χ2 (1, N = 105) = 1.77, p = .129.  Excessive gambling use 
was reported by 12% of post-bariatric cases and 19.6% of controls, χ2 (1, N = 106) = 1.15, p = 
.211.  Excessive video game play was reported by 22% of post-bariatric cases and 19.6% of 
controls, χ2 (1, N = 106) = .09, p = .476, and excessive sexual behavior was reported by 12% of 
post-bariatric cases and 19.6% of controls, χ2 (1, N = 107) = .92, p = .252.  
Discussion 
This study examined the proportion of substance abuse treatment patients with a history 
of bariatric surgery.  Findings indicate that 2.8% of the total treatment seeking sample at 
Brighton Hospital was positive for bariatric surgery history, consistent with an earlier report 
from our research team (Saules et al., 2010).  As in that earlier report, again it seems that this 
estimate may not fully capture the magnitude of this phenomenon.  Specifically, bariatric status 
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was not entered into the EMR for 11 of the 56 bariatric patients who were recruited for the 
present study; in other words, approximately 20% of identified cases failed to have this surgical 
history status entered into the EMR.  Extrapolating from these figures, if the total of 118 cases 
identified from EMR data is actually 20% under the true number of bariatric patients who were 
admitted, then the “true” number of cases may be roughly 148 patients (i.e., 148-(148*.2)=148-
29.6≈118), which would yield an estimated prevalence of 3.2% (148/4568).  While the exact rate 
cannot be known, it is clear that not all cases were entered into the EMR, so the prevalence 
estimate of 2.8% is, if anything, an underestimate.  Incomplete data entry is also suggested by the 
finding that among the bariatric cases that had multiple treatment admissions 65.3% failed to be 
diagnosed during one or more of their admissions.  This suggests that the actual prevalence of 
post-bariatric surgery patients in substance abuse treatment may be much higher than what we 
are able to estimate from the available data.  Therefore, post-bariatric development of substance 
use disorders may be even more pervasive than the current investigation directly observed.  
To put our prevalence estimate in context, an estimate of the proportion of the general 
population that has had bariatric surgery would be helpful.  Although the total number of 
bariatric surgeries performed to date is unknown, a recent report by Nguyen and colleagues 
(2011) estimates that approximately 54.2 procedures were performed per 100,000 adults in 2008. 
Additionally, the ASMBS estimate of surgeries performed suggests that less than one percent of 
those who are medically eligible are receiving bariatric surgery (ASMBS). While it is difficult to 
translate these estimates to a clear underestimate of the proportion of the general population with 
a bariatric surgery history, they do not translate to even close to 2.8% of the general population.  
Therefore, the present study provides additional support that post-bariatric surgery patients may 
be overrepresented in substance abuse treatment facilities.  
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The primary aim of this investigation was to examine differences between post-bariatric 
surgery patients enrolled in substance abuse treatment versus non-bariatric substance abuse 
treatment patients.  Several unique demographic differences emerged when examining these two 
groups.  Notably, post-bariatric surgery patients were significantly more likely to be female.  
These findings are consistent with evidence by Saules and colleagues (2010) and coincide with 
data that females are more likely to receive bariatric surgery (Poulose et al., 2004; Smoot et al., 
2006).  It is well known that men are overrepresented in substance abuse treatment programs 
(Dawson, 1996).  Therefore, female post-bariatric patients who seek substance abuse treatment 
may represent an atypical group and consequently may have unique treatment needs.  The 
implications of potential treatment needs will be discussed later. 
Post-bariatric patients were also significantly more likely to be currently married or living 
with a partner, whereas non-bariatric patients were more likely to be single, divorced or 
separated.  Few empirical studies have examined post-operative relationship status among weight 
loss patients.  The current investigation found that 62.5% of post-bariatric patients were married 
or living with a partner, which is consistent with the majority of studies finding roughly 54-78% 
of post-bariatric patients are married (Guisado-Macías, Vaz Leal, López-Ibor, Rubio, & Garcia 
Caballero, 2004).  Anecdotally, weight loss surgery patients often report concerns about 
relationship stability and risk of divorce after surgery (Applegate & Friedman, 2008), but data 
from a well-designed follow-up studies suggests that marital relations may actually improve after 
surgery (Hafner, 1991; Rand et al., 1984).  Interestingly, the data suggest that for patients who 
report poor relationship quality prior to surgery, the trend tends to continue after surgery, with 
the majority of relationships remaining stable (Applegate & Friedman, 2008).  
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The current study had low statistical power for comparing the small sample of Relapsers 
to the larger NOU group.  It is important to note that although the minimum power requirement 
was not achieved, significant differences were found, suggesting these two groups may have 
separate etiologies and treatment needs.  First, it is notable that 60% of the post-bariatric patients 
were classified as NOU’s; further study of this group is warranted.  A better understanding of 
predictors of new onset substance use is warranted.    
Primary Research Hypotheses 
When do post-bariatric patients develop problematic substance use? Post-bariatric 
patients reported a significantly later onset for the development of their substance use disorder, 
despite not differing from control substance abuse patients on current age.  Specifically, post-
bariatric patients began first using substances regularly, becoming concerned about their 
substance use, and first entering treatment at a significantly later age than their non-bariatric 
counterparts.  These findings suggest that “typical” (i.e., non-bariatric) substance abusers first 
encounter problematic substance use at a younger age, consistent with the epidemiological 
findings of typical substance use trajectories.  Specifically, those who encounter problematic 
substance use tend to first develop problems around age 18 and this effect tends to decline after 
age 25 (Kessler et al., 2009; Li, Hewitt, & Grant, 2004).  Therefore, post-bariatric patients tend 
to first encounter problematic substance use at a time in life that is not normative for new onset 
development.  Two of the main hypotheses, however, were not supported.  The latency between 
onset of regular use and concerns, and the latency between regular use and treatment seeking, did 
not significantly differ between bariatric and non-bariatric substance abuse treatment patients.     
There was a significant difference regarding the latency between age of development of 
concerns and treatment seeking age; post-bariatric patients experienced a shorter latency between 
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concerns about substance use and treatment seeking.  The “telescoping” effect suggests that 
gender differences emerge in the course and development of problematic alcohol use (Piazza, 
Vrbka, Yeager, 1989).  More specifically, this research examines onset, or initiation of 
“landmark events” in alcohol-related problems among treatment-seeking samples and finds that 
women tend to develop problematic use later in life than men, yet quickly develop problems and 
seek treatment more expeditiously  (Keyes, Martins, Blanco, & Hasin, 2010; Randall, Roberts, 
Del Boca, Carroll, Connors, & Mattson, 1999).  Given that our post-bariatric sample was 
predominantly female, perhaps these findings are best explained by the “telescoping” effect 
associated with gender, rather than something unique about bariatric surgery patients who 
develop post-surgical substance use.  However, the results did not find evidence of telescoping 
when examining the total sample, and the control sample, therefore it appears these results may 
be related to bariatric status, rather than gender.   
Alternatively, pre-surgical obesity may serve as a protective factor against the 
development of substance use disorders.  As previously discussed, substance abuse and obesity 
in the general population do not appear to be significantly related, although these findings are 
often inconsistent.  Additionally, post-bariatric patients may have greater exposure to medical 
professionals if they participate in post-surgical care which may contribute to greater access to 
medical intervention.   
Although Relapsers reported using alcohol earlier and becoming concerned about their 
substance use at an earlier age, NOU’s and Relapsers did not significantly differ on any of the 
latency ages.  However, more power may be needed to detect significant differences between 
these groups, as there were only 16 (out of 23) Relapsers who provided data for all of these 
variables. In one respect, a history of substance abuse could be a risk factor for post-surgical 
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substance relapse which may also mean that Relapsers could be more likely to identify their 
post-surgical substance use as problematic and thus seek treatment more quickly.  However, it 
may be relevant to examine the bariatric population in general to examine those with pre-surgical 
problematic substance use who do not develop post-surgical substance abuse.  A recent 
dissertation examined a wide sampling of post-bariatric surgery patients and found that the 
majority (70%) of patients who had problematic substance use before surgery did not relapse 
afterwards (Ivezaj, 2011).   
Are post-bariatric substance abuse treatment patients more likely than “typical” 
substance abuse treatment patients to be diagnosed with alcohol use disorders? Post-
bariatric patients were significantly more likely to be diagnosed with alcohol withdrawal than 
were their non-bariatric counterparts. Contrary to the previous report by Saules and colleagues 
(2010), bariatric patients in this study were also more likely to be diagnosed with alcohol 
dependence.  Therefore, results from the current investigation suggest that post-surgical alcohol 
use may confer high risk for the development of alcohol use disorders, both dependence and 
withdrawal.  This observation of high reinforcing properties of alcohol among bariatric patients 
(inferred from high rates of alcohol-related diagnoses) is buttressed by experimental studies that 
suggest post-bariatric surgery patients have an increased sensitivity to alcohol.  For instance, a 
recent case-crossover study (Woodard, Downey, Hernandez-Boussard, & Morton, 2010) 
examined bariatric patients pre- and post-operatively at three and six months follow-up and 
found that bariatric surgery patients had a breath alcohol level well above the legal limit (i.e., 
above 0.08) after drinking a single glass of wine.  These findings are particularly salient given 
that the bariatric patients served as their own controls, affording a within subject examination of 
changes in bariatric patients’ alcohol metabolism pre- and post-surgery.  Consistent with prior 
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findings (Hagedorn, Encarnacion, Bratt, & Morton, 2007; Klockhoff, Naslund, & Jones, 2002), 
the researchers found that the post-bariatric patients experienced a higher peak breath alcohol 
content (BAC) and took longer to return to baseline than prior to surgery.  Interestingly, these 
patients also reported an increased total number of symptoms of intoxication after surgery. 
Therefore, the authors suggest because post-bariatric patients’ bodies respond differently to 
alcohol these patients may be less able to identify when they become intoxicated after surgery, 
which may lead to overindulgence.  Maluenda and colleagues (2010) recently used a similar 
design to examine the effect of alcohol among a sample of bariatric patients who received the 
Laparoscopic Sleeve Gastrectomy procedure, and consistent with the aforementioned studies, 
alcohol absorption was significantly altered after surgery.  In part, physiological changes in the 
absorption and response to alcohol for post-bariatric patients may explain the differences 
observed in alcohol use disorders in the present study.  The current findings therefore indicate 
that bariatric surgery patients may be at risk for developing alcohol-use disorders after surgery.  
However, all bypass patients have the same altered physiology as a byproduct of surgery, but 
clearly, not all develop post-surgical substance use disorders.  Therefore, further research to 
advance our understanding of which bariatric patients are most at risk for the development of 
post-surgical substance use disorders is warranted.  
Contrary to these findings is a recent report which examined rates of lifetime and current 
alcohol use disorders and found that bariatric surgery patients had prevalence rates that were 
comparable to the general population (Suzuki, Haimovici, & Chang, 2010).  The study however 
had several limitations, most notably, a poor response rate of only 9%; thus, the actual 
emergence of post-surgical alcohol abuse may actually be much greater, as there may be a 
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response bias.  Future research is warranted to examine substance use disorders among treatment 
and non-treatment seeking samples of post-bariatric patients.  
 Contrary to the findings by Saules and colleagues (2010), in the current investigation 
post-bariatric patients did not differ significantly from controls in the minimum or maximum 
number of drinks per day consumed.  There were several limitations present however; the 
previous report was able to match participants to controls on age, gender, and time of admission, 
while the present investigation was only able to match participants on gender.  For instance, one 
study found that transitional life events can affect the course of alcohol dependence—events 
such as marital transitions and becoming a parent positively contributed to the likelihood of 
recovery from alcohol dependence (Dawson, Grant, Stinson, & Chou, 2006).  Additionally, Pabst 
and colleagues (2011) recently reported on age-related differences in DSM-IV criteria for 
alcohol dependence, such that those 18-24 years of age were significantly more likely to meet 
criteria for the “larger/longer” and “time spent” criteria.  In sum, age of the participants may 
have affected the results.  Future research should attempt to replicate the previous findings by 
Saules et al. as it is unclear if post-bariatric alcohol use is more severe than that experienced by 
the general treatment population.   
 Do post-bariatric patients use fewer substances than the “typical” substance user? 
Bariatric and non-bariatric substance abuse treatment patients did not differ statistically 
significantly in the total number of substances used between.  Interestingly, an examination of 
the types of substances used revealed significant differences.  Specifically, controls reported 
current use of cocaine/crack and marijuana, and lifetime use of cigarettes, significantly more 
than the post-bariatric sample.  These differences could be a function of the time at which post-
bariatric patients are developing problems with substances.  Given that the majority developed 
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problematic use after surgery, significantly later in life than controls, perhaps post-bariatric 
patients did not have a long enough history of abuse to become exposed to more types of 
substances.  Furthermore, a limitation to the substance use categories was that the opiate 
category includes both heroin and prescription substance use. Therefore, this may account for the 
lack of observable differences between the two groups, as opiates may be more readily available 
to post-bariatric patients who are likely to have received post-surgical pain medications.   
Relapsers reported using significantly more substances than NOUs.  Therefore it seems that new 
onset development is associated with less varied drug use.  In particular, Relapsers reported more 
significant marijuana and tranquilizer use, in addition to reporting a greater likelihood of ever 
smoking cigarettes.  Relapsers may have more experience with different types of drugs, as they 
have a longer history of substance use.  However, in terms of overall severity of substance abuse, 
the two groups appear similar, as there were no significant differences in the AUDIT total 
severity scores 
Do post-bariatric patients experience a poorer quality of life? While post-bariatric 
patients did not report a significantly poorer physical health, social or environmental quality of 
life, they did however report worse psychological quality of life.  While it is generally accepted 
that the morbidly obese, particularly surgical candidates, report a significantly decreased quality 
of life (van Nunen et al., 2007; Sarwer et al., 2005), post-surgical outcomes of QOL are less 
understood.  For instance, several reviews suggest that the data on health-related quality of life 
among post-bariatric patients are often fraught with methodological limitations, such as age, 
gender, time since surgery, and amount of weight lost (Bocchieri, Meana, & Fisher, 2002; van 
Hout & van Heck, 2009; van Nunen et al., 2007).  The present study however did not find that 
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age or gender was significantly associated with QOL.  Furthermore, while the bariatric sample 
had a significantly higher BMI, it was not related to any of the QOL dimensions.   
Interestingly, the present study did not find differences between the post-bariatric sample 
and controls on the physical domain of QOL which is somewhat inconsistent with prior research 
related to health-related quality of life.  For instance, a recent study found that HRQOL 
improved at one-year post-surgical follow-up and these results were maintained at 5-year follow-
up; however, the authors report that scores did not reach the level of the age and gender-
standardized general population and that QOL did not improve significantly between 1 and 5 
year follow-ups (Helmiö, Salminen, Sintonen, Ovaska, & Victorzon, 2011).  The present 
investigation did not assess for pre-surgical QOL it is unknown if there was a change (or 
presumably an improvement) in QOL after surgery.  However, in general, those in the morbidly 
obese category tend to experience the poorest QOL (Sarwer et al., 2005; van Nunen et al., 2007).   
The current QOL scores among both groups (i.e., post-bariatric and controls) were 
considerably low; in fact, QOL scores obtained in all domains for both groups were considerably 
lower than community norms (Hawthorne, Herrman, & Murphy, 2000). Therefore, the QOL 
findings may be specific to substance users.  QOL has not been heavily investigated among 
substance abuse treatment populations, with less than 100 studies on QOL among substance 
users published in the last 20 years (Laudet, 2011).  Laudet suggests that the majority of studies 
that assess QOL among substance users have primarily been conducted among alcohol 
dependent patients.  More specifically, several reviews suggest that QOL is very poor among 
alcohol dependent participants (Donovan, Mattson, Cisler, Longabaugh, & Zweben, 2005; 
Foster, Powell, Marshall, & Peters, 1999; Laudet, 2011) and perhaps among opiate-dependent 
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individuals (De Maeyer, Vanderplasschen, & Broekaert, 2010). However, for unknown reasons, 
QOL in addiction research is still in the infancy stage and therefore future research is warranted.  
The difference in psychological quality of life among post-bariatric patients and controls 
however is quite notable as the QOL scores obtained from the control substance abuse subjects 
were already considerably low.  The WHOQOL-BREF measure taps constructs within the 
psychological QOL domains such as bodily image and appearance, negative feelings, positive 
feelings, self-esteem, spirituality, religion, and personal beliefs, thinking, learning, memory, and 
concentration.  The individual items that were significantly different in the psychological QOL 
domain were “enjoying life,” “bodily appearance,” and “negative feelings such as blue mood, 
anxiety, or depression.”  Therefore, it appears that the differences observed are not solely due to 
concerns about body image or appearance.  
Additionally, no significant differences were observed between Relapsers and NOUs on 
any of the QOL variables.  Therefore, the QOL differences between bariatric patients and 
controls  are likely due to bariatric status rather than the chronicity of the substance use disorder. 
Are post-bariatric patients engaging in other excessive behaviors? Contrary to 
expectations, post-bariatric patients and controls did not differ on any of the behavioral excess 
variables. The assessment of behavioral excesses in this study suffered from several limitations.  
The behavioral excess questionnaire was created by the researchers therefore reliability, validity, 
and normative data are unavailable.  Therefore, the development of a behavioral excesses 
measure is warranted.     
Additionally, excessive, or compulsive shopping behavior wasn’t included in the 
questionnaire.  Excessive shopping in particular may be salient for post-bariatric patients given 
the significant reduction in weight for the majority of patients.  It would not be surprising, 
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therefore, that among those who do achieve significant weight loss would need to acquire clothes 
that fit them appropriately.  Although compulsive shopping has not been systematically 
investigated among post-bariatric patients a recent dissertation examined post-operative 
problematic shopping among the pre-surgical binge eaters and found that higher pre-surgical 
binge eating scores predicted post-operative shopping/buying behaviors (Cook, 2011).  Cook 
suggests that compulsive shopping among post-bariatric patients may be a way to manage 
emotions, as in general there are high rates of Axis I disorders, such as depression or anxiety.  
Alternatively, increased engagement in excessive shopping behavior could be a consequence of 
increased exposure by virtue of having to purchase new clothing as they lose weight.  For 
instance, the cue exposure or cue reactivity literature suggests that exposure to environmental 
stimuli contributes to the behavioral response. Although the behavioral theory of the effect of 
cues on behavior has generally been applied in substance addiction (Niaura, 2000), it has also 
been applied to eating-disordered patients (Giel, Teufel, Friederich, Hautzinger, Enck, & Zipfel, 
2011; Jansen, 1998).   
During the qualitative interview within this investigation several patients enrolled in this 
study disclosed excessive shopping behavior, post-surgery.  However, excessive shopping was 
not systematically assessed in either the interview or survey portion of the study and discussion 
of shopping behavior was only brought up if a participant disclosed the behavior.  Therefore, 
future research should systematically assess excessive or compulsive shopping behavior in post-
bariatric patients. 
 The addiction transfer theory suggests that patients who overcome an addictive disorder 
may subsequently develop another addiction, thus “transferring” their addictive tendencies based 
on the assumption that an underlying addictive pathology is driving the behavior.  The current 
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findings do not support the notion that addiction transfer for the development of other excessive 
behaviors (e.g., gambling), occurs among post-bariatric patients, as post-bariatric patients did not 
significantly differ when compared to controls.  However, a major limitation to this finding is 
that pre-surgical behavioral excess was not assessed. Therefore, it is unknown if the patient’s 
behavior deviated from their previous pattern, or if the current rates are typical for the sample.   
It is possible that pre-surgically, bariatric patients may tend to use food as a coping 
mechanism or, said differently, it may be their “drug of choice.”  Interestingly, roughly half of 
the post-bariatric patients in this sample reported binge eating behavior (i.e., eating within a 2-
hour period what most people would regard as an unusually large amounts of food) prior to 
surgery, with 85% of those reporting binge eating also indicating feelings of loss of control, and 
approximately 39% of the total bariatric sample meeting full criteria for BED prior to receiving 
surgery.  This is consistent with previous research on retrospective reporting of BED among 
bariatric surgery candidates’ ranges, which ranges from 37.5% to 49% (Niego, Kofman, Weiss, 
& Geliebter, 2007).  Our investigation did not directly examine whether pre-operative binge 
eating predicts post-surgical substance use.  Guisado and Vaz Leal (2003) compared morbidly 
obese bariatric surgery candidates with and without binge eating disorder and found that pre-
operative binge eaters reported significantly more symptoms of alcohol dependence after 
surgery.  Future research should examine pre-surgical eating behavior to determine if perhaps 
post-bariatric patients are “transferring” a food addiction to post-surgical substance use.  While 
prospective studies have examined rates of lifetime and current rates of substance abuse among 
bariatric patients (Kalarchian et al., 2007; Mauri et al., 2008; Mühlhans, Horbach, & de Zwaan, 
2009; Rosenberger, Henderson, & Grilo, 2006), longitudinal studies in particular are needed to 
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understand if perhaps eating behavior manifests differently after surgery, or perhaps is 
“transformed” into problematic substance use, or another form of addiction.  
Significant differences emerged regarding binge eating behavior and BED rates within 
Relapsers and NOUs.  Specifically, Relapsers were more likely to report binge eating and meet 
criteria for BED.  The average time sober prior to surgery among Relapsers was 9.18 years, with 
64.3% of Relapsers reporting no substance use 5 or more years prior to surgery.  This suggests 
that the majority of bariatric patients in this sample were not actively using substances during the 
pre-surgical process.  Relapsers therefore may have used food as a coping strategy prior to 
seeking surgery and subsequently relapsed to drugs or alcohol after surgery when food was no 
longer able to be “abused.”  Future research is warranted to examine what risk factors may relate 
to NOU status.  In particular, assessment of food addiction and trajectories of substance use may 
be helpful to understand the unique emergence of post-surgical substance use after surgery.  
Treatment Implications. Post-bariatric patients may require tailored treatment given the 
significant differences that emerged when comparing them to general substance-using treatment 
patients.  The majority of post-bariatric patients were female, married or living with a partner, 
and many developed problems with alcohol and other drugs significantly later in life.  
Consequently, in a group therapy setting (which is common for many substance abuse treatment 
programs), bariatric patients many of whom may have only recently developed problematic use, 
may have trouble relating to other patients with such different demographic factors and those 
with a long and more pervasive history of substance use.    
The average time it took for post-bariatric patients to become concerned about their 
substance use—relative to their age of surgery—was only 1.6 years (SD = 1.62).  Whether or not 
the aforementioned differences identified in developmental trajectories are a consequence of 
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gender or perhaps of bariatric status, post-bariatric patients often receive post-surgical care 
related to surgery.  Post-surgical assessment of substance use among bariatric patients is 
therefore suggested during routine follow-up visits with the bariatric treatment team.  This may 
allow physicians an opportunity to intervene if a patient is struggling with post-surgical 
addiction.   
 Additionally, evidence from the present study suggests that post-bariatric patients in 
substance abuse treatment may be more likely to experience alcohol withdrawal, in addition to 
alcohol dependence.  Therefore, many post-bariatric patients in substance abuse treatment may 
need detoxification services to safely overcome problems with alcohol. At a minimum, post-
surgical recommendations made to bariatric candidates could include psychoeducation regarding 
substance use after surgery. The American Association of Clinical Endocrinologists, the Obesity 
Society, and the American Society for Metabolic and Bariatric surgery all conclude that current 
drug or alcohol use should serve as an exclusionary criterion for bariatric surgery however 
anecdotally participants within this study reported that the pre-surgical screening period did not 
have a significant impact on their behavior post-surgery.  Ivezaj and colleagues (in press) 
recently explored the qualitative interview data from this investigation and found that roughly 
71% of representative sample (n = 24) reported recommendations that include more information 
of the associated risks of substance use post-surgery.  Therefore, perhaps psychologists or other 
health-care providers may have a more effective role after surgery, particularly when post-
bariatric patients are transitioning and experiencing major changes.     
  The differences in psychological QOL and sexual abuse history reported by post-bariatric 
patients may highlight the need for increased psychological care after bariatric surgery.  These 
results are consistent with evidence that bariatric surgery patients have elevated rates of sexual 
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abuse/attack when compared to non-bariatric samples (Mahony, 2010).  The reporting of sexual 
abuse among the post-bariatric population itself is so varied that rates range from 16-32%.  The 
current investigation did identify a significantly elevated rate when comparing post-bariatric 
patients to controls with roughly half (51%) of post-bariatric patients indicating a history of 
sexual abuse.  However, the finding itself may be an underestimate,  given that this variable was 
not systematically assessed, but rather, could only be noted as present if it was so indicated in the 
patients’ charts.  Although the examination of post-bariatric patient’s abuse history was not a 
primary aim of this investigation, future research should assess how abuse or perhaps trauma, 
more generally, relates to psychological quality of life within this population.  Additionally, 
given that trauma history, or post-traumatic stress disorder, was not assessed, future research 
should investigate these variables among a substance-using post-bariatric sample.   
Limitations 
 The current investigation had several limitations that should be noted.  The 
generalizability of these findings may be limited to post-bariatric surgery patients who are 
similar to the study’s sample characteristics. For instance, the study sample consisted primarily 
of middle-aged, Caucasian, females.  Furthermore, the bariatric and control groups were limited 
to current inpatient substance abuse patients—which are not reflective of the majority of 
substance users, particular those who do not seek treatment.  Future research should examine 
post-bariatric patients who are in other types of substance abuse treatment programs, in addition 
to non-treatment seeking populations.  Additionally, the present study was not able to match 
participants on variables such as race, age, sex, and time of admission as the previous report by 
Saules and colleagues (2010) was able to do.   
  
74 
Another limitation of this investigation was the assessment of several of the relevant 
variables.  Questions that assessed age of onset for substance abuse were asked retroactively 
through a self-report questionnaire; therefore, the accuracy of the patients’ estimates may be 
questionable.  Furthermore, the time at which patients were recruited to participate in the current 
investigation was not systematic—therefore patients  may have participated during their first day 
of treatment, while others may have been recruited after receiving several months of care.  
Patients who are initially admitted may appear highly distressed which may impact their 
responses.   Lastly, the current study was sufficiently powered to detect significant mean group 
differences for the majority of hypotheses, yet in several instances, desired power was not 
achieved.  Therefore, caution is advised with respect to the exploratory analyses, particularly 
those comparing NOU’s and Relapsers.  
Conclusion 
Overall, findings suggest that post-bariatric patients may be overrepresented in substance 
abuse treatment programs. Post-bariatric patients in such programs are more likely to be female, 
married or living with a partner, have poor psychological quality of life, are more likely to have 
histories of sexual abuse, develop problematic substance use later in life, develop problematic 
substance use shortly after surgery, and seek treatment quickly after acknowledging concern 
regarding their addiction.  Longitudinal research is needed to examine a more accurate trajectory 
of substance development among bariatric patients, particularly in relation to the patient’s age at 
surgery.  Specifically, it may be relevant to examine when post-bariatric patients develop 
problematic substance with respect to the age at which they became obese.  These findings may 
highlight the need for tailored treatment for post-bariatric patients who are currently in substance 
abuse treatment, as they are more likely to experience an alcohol use disorder; in addition, they 
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report a significantly poorer psychological quality of life and are more likely to report a history 
of sexual abuse.  Additionally, post-bariatric patients are disproportionally diagnosed with 
alcohol dependence and withdrawal when compared to the general substance-using treatment 
population. These findings may highlight the need for tailored treatment for post-bariatric 
patients who are currently in substance abuse treatment as they are more likely to experience 
alcohol use disorders, in addition to reporting a significantly poorer psychological quality of life 
and a history of sexual abuse.  Future research should attempt to replicate these findings, ideally 
in a larger and more diverse sample.   
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Appendix A 
Demographic, Weight-Related History and Substance Trajectory Questionnaire 
 
A. Background Information 
 
1. How old are you?   _____  years 
 
2. Are you… 
   
  Female  
  Male    
  Transgender 
 
3.  Please check the box(es) below which correspond to the racial/ethnic groups you belong to: 
 
  Black or African-American 
  White or Caucasian   
  Hispanic or Latino/a 
  Native American 
  Asian or Asian American 
  Middle Eastern 
  Other (Please Specify:   _____________________________________________  
 
4.   How many years of education have you completed?   _________  years 
(NOTE: Completing High School or its equivalent = 12 years) 
 
5.  What is your current relationship status? 
 
  Married 
  Living with partner (same sex) 
  Living with partner (opposite sex) 
  Single (never married, not living with partner)   
  Divorced 
  Remarried 
  Widowed 
  Separated 
  Other (Please Specify:   ____________________________________________  
 
6.  What is your current employment status? 
 
  Working full time (>35 hours/week) 
  Working part-time, regular hours 
  Working part-time, irregular hours 
  Unemployed - student  
  Unemployed - homemaker 
  
98 
  Unemployed – other 
  Retired 
  Disability 
  Military 
 
7.  What is the economic status of your current household?  
 
  We have barely enough to get by  
  We have enough to get by, but no more  
  We are solidly middle class  
  We have plenty of “extras”  
  We have plenty of “luxuries” 
  Don’t know/unsure/prefer not to say 
 
8.  What is your annual household income?  
 
  >$150,000 
  $100,000-$149,000  
  $75,000-$99,000  
  $50,000-$74,000  
  $25,000-$49,000 
  $10,000-$24,000 
  <$9,000   
  Don’t know/unsure/prefer not to say 
 
 B1.  Weight-related Health History 
 
1.  What type of weight-loss (bariatric) surgery have you had?  
 
  LAP-BAND adjustable gastric banding (LAGB) 
  Roux-en-Y gastric bypass 
  Vertical banded gastroplasty (“stomach stapling”) 
  Biliopancreatic diversion with duodenal switch  (BPD) 
  Don’t know, not sure 
 
If you are not sure, please provide some details about what you can recall about the 
procedure that you had: 
 
  
 
 
 
 
 
 
  
99 
 
2a. Were there any surgical complications?   No     Yes  
 
2b.  If you experienced any complications, please describe what happened: 
 
  
 
 
 
 
 
 
        Actual or approximate 
                         DATE 
 
3a. What was the date of your bariatric surgery?    ___ /____ / ___ 
 
3b.  How old were you when you had bariatric surgery?..................._______years old 
 
3b. How old were you when you first begin to regularly  
  use alcohol?..............................................................._______years old 
 NOTE: Regular use = 2 or more times per week 
 Check here if not applicable   
 
3c. How old were you when you first begin to regularly  
  use drugs? ...............................................................________years old 
 NOTE: Regular use = 2 or more times per week 
 Check here if not applicable   
 
3d. When did you or others first become concerned  
 about your alcohol/drug use? ..............................................._______years old 
 
 
3e. How old were you the first time you entered 
  alcohol/drug treatment? ........................................._______years old 
 
 
4a.  Before you had any form of weight loss surgery, had you been diagnosed with any of the 
conditions listed below?  (Check all that apply) 
 
 Chronic pain 
  Diabetes (Type II) 
  GERD  (Gastroesophageal reflux disease)  
  Hypertension (High Blood Pressure) 
  High Cholesterol 
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  Infertility 
  Obesity Hyperventilation Syndrome (OHS) 
 Osteoarthritis 
  Sleep Apnea 
 Urinary Stress Incontinence (involuntary loss of urine that occurs during physical activity, 
such as coughing, sneezing, laughing, or exercise) 
 
4b.  If you checked any boxes in the previous question, please indicate the extent to which the 
condition has changed since your weight loss surgery. 
  
  Worsened Unchanged  Improved      No longer a  
        problem  
 
Chronic pain                                                           
Diabetes                                                                
GERD                                                                                               
High Blood Pressure                                                                        
High Cholesterol                                                                            
Infertility                                                                                         
OHS                                                                                                  
Osteoarthritis                                                                                    
Sleep Apnea                                                                                   
Incontinence                                                                                     
 
 
5.  How tall are you?  ______ feet and ______ inches 
 
6.   What is/was your highest adult weight (not including pregnancy)? ______ pounds 
  What year were you at your highest weight? _______________________ 
 
7.  What did you weigh just before your weight loss surgery?            ______ pounds 
 
8. What is your weight now?                                                               ______ pounds 
 
9. What do you consider to be your ideal weight?                                _____ pounds 
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Appendix B 
AUDIT-R 
Substance Use (AUDIT-R) 
 
1. Before entering treatment, how often did you have any of the following: 
 
 Not  
at all 
Monthly Weekly Several 
times/ 
week 
Daily 
Moderate 
Use  
Daily 
Heavy 
Use 
Alcohol        
Cocaine/crack       
Other Stimulants (Ritalin, 
Amphetamine, Adderall, 
Methamphetamine, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Heroin or other opiates 
(Vicodin, Darvon, Codeine, OxyContin, 
Fentanyl, Methadone,  LAAM, 
BUprenorphine, Suboxone, Oxycodone, 
Oxycontin, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Marijuana (Weed, Blunts, Hash)        
Tranquilizers (Xanax, Klonopin, 
Valium, GHB, Roofies, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Hallucinogens (LSD, Ecstasy, 
Mushrooms, Ketamine, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.  Before you started treatment, on a day when you would drink any alcohol or use other drugs, how 
many drinks (alcohol), lines (cocaine), rocks (crack), joints (marijuana), doses (heroin) or pills would you 
typically take? 
 
 None 1-2 3-4 5-6 7-9 10 or 
more 
Alcohol        
Cocaine/crack       
Other Stimulants (Ritalin, 
Amphetamine, Adderall, 
Methamphetamine, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Heroin or other opiates 
(Vicodin, Darvon, Codeine, OxyContin, 
Fentanyl, Methadone,  LAAM, 
BUprenorphine, Suboxone, Oxycodone, 
Oxycontin, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Marijuana (Weed, Blunts, Hash)        
Tranquilizers (Xanax, Klonopin, 
Valium, GHB, Roofies, etc.) 
 
 
 
 
 
 
 
 
 
 
 
 
Hallucinogens (LSD, Ecstasy, 
Mushrooms, Ketamine, etc.) 
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3.  Before you started treatment, how often would you have 6 or more drinks per day, 1 or more 
joints/lines/rocks/doses per day, or 3 or more pills per day?  
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
4.  During the year before you started treatment, have you found that you were unable to stop drinking or 
using other drugs once you had started?  By this, we mean that you planned to only use a certain amount, 
but unintentionally used more than that. 
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
5.  During the year before you started treatment, how often did you fail to do what was normally expected 
of you because of drinking alcohol or using other drugs? 
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
6.  During the year before you started treatment, how often did you need a drink or drug first thing in the 
morning to get yourself going after a heaving drinking or drug use episode the night before? 
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
7.  During the year before you started treatment, how often did have a sense of guilt, regret, or remorse 
after drinking or using drugs? 
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Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
8.  During the year before you started treatment, how often were you unable to remember what happened 
the night before because you had been drinking or using other drugs? 
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
9.  Have you or someone else been injured as the result of your drinking or other drug use? 
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
 
10.  Before you started treatment, had a relative, friend, doctor, or other health care worker expressed 
concern about your drinking or drug use, or suggested you should cut down?  
 
Alcohol      Drugs 
 Never       Never 
 Less than monthly      Less than monthly  
 Monthly       Monthly 
 Weekly       Weekly 
 Almost daily      Almost daily   
 Daily       Daily 
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Appendix C 
Behavioral Excess Questionnaire 
 
G. Behavioral Excesses 
 
During the four weeks before you came to Brighton, how often were you participating in each 
of the following activities: 
 
  Not  
at all 
Several 
days a 
week 
More 
than 
half the 
days 
Nearly 
every 
day 
 
Surfing the internet for more than two hours (not for 
work purposes)  
 
 
 
 
 
 
 
 
 
Gambling (any type) 
 
 
 
 
 
 
 
 
 
Videogame playing 
 
 
 
 
 
 
 
 
 
Sexual behavior outside of a committed relationship  
 
 
 
 
 
 
 
 
 
Eating sweets in amounts that most people would 
consider excessive 
 
 
 
 
 
 
 
 
 
Eating carbohydrates in amounts that most people 
would consider excessive 
 
 
 
 
 
 
 
 
 
Eating large amounts of food very late at night?  
     If yes:  
 Check here   if you would wake up and 
eat after you had already gone to bed.  
 Check here  if you would typically do this 
before you went to bed?  
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Appendix D 
WHOQOL-BREF 
 
Quality of Life (WHOQOL-BREF) 
 
The following questions ask how you feel about your quality of life, health, or other areas of 
your life. Please choose the answer that appears most appropriate. If you are unsure about 
which response to give to a question, the first response you think of is often the best one.  Please 
keep in mind your standards, hopes, pleasures and concerns. We ask that you think about your 
life in the last four weeks. 
    
     
Very poor Poor  
Neither 
poor nor 
good 
Good 
Very 
good 
1.  How would you rate your 
quality of life?  
1  2  3  4  5  
  
 
     
Very 
dissatisfied 
Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied 
Very 
satisfied 
2.  How satisfied are you with 
your health?  
1  2  3  4  5  
 
 
 The following questions ask about how much you have experienced certain things in the last 
four weeks.  
     
Not at all A little 
A moderate 
amount 
Very  
much 
An 
extreme 
amount 
3.  To what extent do you feel that 
(physical) pain prevents you 
from doing what you need to 
do? 
1  2  3  4  5  
4. How much do you need any 
medical treatment to function in 
your daily life? 
1  2  3  4  5  
5.  How much do you enjoy life? 
1  2  3  4  5  
6. To what extent do you feel your 
life to be meaningful? 
1  2  3  4  5  
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Not at all A little 
A moderate 
amount 
Very  
much 
Extremely 
7.  How well are you able to 
concentrate? 
1  2  3  4  5  
8. How safe do you feel in your 
daily life? 
1  2  3  4  5  
9.  How healthy is your physical 
environment? 
1  2  3  4  5  
 
 
 
The following questions ask about how completely you experienced or were able to do certain things in 
the last four weeks. 
    
Not at all A little Moderately Mostly Completely 
10.  Do you have enough energy for 
your everyday life? 
1  2  3  4  5  
11. Are you able to accept your 
bodily appearance? 
1  2  3  4  5  
12.  Do you have enough money to 
meet your needs? 
1  2  3  4  5  
13.  How available to you is the 
information that you need in 
your day-to-day life? 
1  2  3  4  5  
14. To what extent do you have the 
opportunity to do leisure 
activities? 
1  2  3  4  5  
 
 
 
    
Very poor Poor  
Neither 
poor nor 
good 
Good 
Very 
good 
15.  How well are you able to get 
around, physically?  
1  2  3  4  5  
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Very 
dissatisfied 
Dissatisfied 
Neither 
satisfied 
nor 
dissatisfied 
Satisfied 
Very 
satisfied 
16.  How satisfied are you with 
your sleep?  
1  2  3  4  5  
17.   How satisfied are you with 
your ability to perform your 
activities of daily living? 
1  2  3  4  5  
18. How satisfied are you with 
your capacity to work? 
1  2  3  4  5  
19. How satisfied are you with 
yourself? 
1  2  3  4  5  
20. How satisfied are you with 
your personal relationships? 
1  2  3  4  5  
21. How satisfied are you with 
your sex life?  
1  2  3  4  5  
22. How satisfied are you with the 
support you get from your 
friends? 
1  2  3  4  5  
23. How satisfied are you with the 
conditions of your usual living 
place?  
1  2  3  4  5  
24. How satisfied are you with 
your access to health services? 
1  2  3  4  5  
25. How satisfied are you with 
availability of transportation? 
1  2  3  4  5  
 
The following question refers to how often you have felt or experienced certain things in the last four 
weeks.   
    
Never Rarely 
Quite 
Often 
Vey 
often 
Always 
26.  How often do you have 
negative feelings such as blue 
mood, despair, anxiety, or 
depression?   
1  2  3  4  5  
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Appendix E 
Semi-Structured Interview 
 
Date:_________             Participant ID:   _______ 
Interviewer:___________                              Date of Bariatric Surgery:  ________ 
Type of Surgery:________________ 
Brighton Admission Date:________ 
Brighton Bariatric Project 
Semi-Structured Interview 
 
My name is  ______________.  I am working with researchers from Brighton Hospital and 
Eastern Michigan University to gather information about why some people who have had 
bariatric surgery experience problems with alcohol and other drugs.   You may have already 
participated in the Survey portion of this project, where we asked you a lot of questions about 
your surgery, substance use, efforts to control your weight, and related psychological factors.  
If you did complete the survey, I would first like to go over it with you, to see if you had any 
questions about the items on the survey, or if you would like to add any additional information to 
what you told us on the questionnaires.   
 <INTERVIEWER:   USING A COPY OF THE PARTICIPANT’S SURVEY, 
IDENTIFIED ONLY BY SUBJECT CODE, GO OVER SALIENT QUESTIONS, 
ESPECIALLY THOSE PERTAINING TO SURGERY vs. ADDICTION TIMING 
AND ASK FOR CLARIFICATION ABOUT ANY ITEMS THAT WERE SKIPPED 
OR ANSWERED IN AN INCONSISTENT OR UNCLEAR MANNER, RECORD 
ANY NEW INFORMATION DIRECTLY ON THE SURVEY COPY, NEXT TO 
THE ITEM(S) TO WHICH THE COMMENTS PERTAIN> 
 
Now, I would like to ask you to tell me about the type of screening process you went through 
before your bariatric surgery?   
1. Do you recall where you had the surgery and who did the pre-surgical screening? 
2. Do you recall what types of assessments you had?    
3. Do you recall if you were asked about your use of alcohol or other drugs?  
4. If so, what information did you share with the person who was doing the evaluation?    
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5. And, if you were asked, did you share complete information about your use of alcohol 
or drugs?   Did you tell the person about the types and amounts of alcohol/drugs you 
might have been using at that time?  Why or why not?  
6. If you were using alcohol/drugs at that time, but did not reveal it, was it because you 
were concerned about how it might impact whether you would be allowed to have the 
surgery?  If yes, tell me more about that… 
7. Were you asked about your family history of alcohol or drug use?  If yes, what do 
you recall being asked, and what did you say? 
8. Were you asked about whether you engaged in “binge eating”?  By that, we mean 
eating large amounts of food in short periods of time, and feeling like you couldn’t 
control your eating behavior.  
9. What other types of things were your treatment providers concerned about before 
they authorized surgery?  What kind of information did you provide in response to 
those concerns?  
Now, I would like to know a bit about what has happened since your surgery. 
10. What sorts of recommendations were you given about behavioral changes to make so 
that you could have the best possible outcome from the surgery?  
11. What kinds of behavioral changes were you able to make to support your weight loss 
efforts after the surgery?  
12. How much weight did you lose after the surgery?  
13. Have you gained any of the weight back?  If so, how much?  Why do you think this 
happened? 
14. We are particularly interested in the timing of bariatric surgery relative to the 
development of your substance abuse problems.  Were you aware of or concerned 
that you might have a problem with drugs or alcohol before you had bariatric 
surgery?  If yes, please tell me a bit about that. 
15. Before your surgery, had other people expressed concerns about your use of alcohol 
or drugs?  If yes, please tell me more about that. 
16. Had you ever had alcohol or drug treatment before your surgery? If yes, please tell 
me more about your experiences with treatment. 
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17. Do you feel like your problems with alcohol/drugs began AFTER you had bariatric 
surgery?  If yes, please describe how you began or increased your use of 
alcohol/drugs, and how you became concerned that it might be a problem for you.  
18. What do you think the relationship is between your eating behavior and alcohol/drug 
use?   
a) Are they connected in any way?   
b) Is one a substitute for another?  
c) Or do you think they are unrelated types of problems?  
  If Yes, please tell me about how you formed that impression. 
19. Are there any other thoughts, observations, or impressions you can share that might 
help us better understand why some people enter substance abuse treatment after they 
have had bariatric surgery?  
20. Do you have any ideas about what might help post-bariatric surgery patients avoid 
problems with alcohol or other drugs? 
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Appendix F 
Chart Review Data Form  
 
Admission Dates (year of admission:_______) Demographics (circle) 
Admission Date: Discharge Date: Age: Marital Status: M (1)   S (2)    D (3)  W (4)    
Other:_______ (5) 
Rehab Admission: Rehab Discharge: Gender:     M(1)   F(2) Education: 12=HS 14=Some college 
16=Bach. 17=Some grad. 18=Masters 
Detox Admission: Detox Discharge: Employ.:   Y(1)    N(2) Emp. Type:  FT(1)       PT(2)    Unemp.(3) 
Student(4)  Other=_____(5)      Unk(-9) 
IOP Admission: IOP Discharge: Height (inches): Race: B(1)   W(2) Other=_____(3) Unk(-9) 
Partial Admission: Partial Discharge: Weight (in lbs): Sex. orient: Hetero (1) Homo(2)  Bi(3)    
Other(4)_______ Unk(-9) 
Physical Health Gastric Bypass and Trauma History 
Chronic Pain: (type)_______ Y(1)           N(2)        Unk(-9)  Year of Surgery:  
Diabetes (II): Y(1)           N(2)        Unk(-9) Weight Lost (in lbs):  
GERD: Y(1)           N(2)        Unk(-9) Surgery Type: Roux en-Y(1)                 Intestinal(2)  
 Lapband(3)                    Unk(-9) 
Hypertension: Y(1)           N(2)        Unk(-9) Physical Abuse: Y(1)                    N(2)                       Unk(-9)   
High Cholesterol: Y(1)           N(2)        Unk(-9) Emotional Abuse: Y(1)                    N(2)                       Unk(-9)   
Osteoarthritis: Y(1)           N(2)        Unk(-9) Sexual Abuse: Y(1)                    N(2)                       Unk(-9)   
Mental Health/Treatment 
DSM-IV diagnoses  
Primary reason for treatment 
1=Alc. 2=Alc.+drug 3=Opiates 4=Bz 5=Poly 6=Amp. 7=Cocaine 
 
Family Hx of Mental Illness? Family_substanceHX:  Yes(1)                No(2)              Unk.(-9) 
Family_subtype: _____________________  
Family_mentalHX:       Yes(1)                No(2)              Unk.(-9) 
Family_mentaltype= __________________ 
# of previous tx. eps./Year of tx. -9=Unk  
# of Didactic Sessions (blue)   
# of Family Sessions (pink) Do not enter—will be obtained from Rosa 
Suicidality hx? Suicide_currentplan:       Yes(1)                No(2)              Unk.(-9) 
Suicide_currentideation: Yes(1)                No(2)              Unk.(-9) 
Suicide_pastattempt:       Yes(1)                No(2)              Unk.(-9) 
Legal troubles? Legal_troubles:               Yes(1)                No(2)              Unk.(-9) 
Legal_type: 
_____________________________________________ 
Substance Use 
Current Smoker? Y(1)             N(2)              Ex(3)           Unk.(-9)  
Smoking_quit: (year,  if quit)_____ 
Cigarettes_perday= (20=1ppd.)______ 
Drugs/Alc used: Self-report 
data, CIRCLE all drugs used, 
1=Yes 2=No 
Alc               THC                     Cocaine/Crack      Amphet         Methamphet            Heroin         
Methadone          Other Opiates  (Specify): _______________ Benzos                     Barbs                    
PCP                     Other: ____________ 
Age of onset / heavy use, for 
each drug UNDERLINED 
above, if known 
Alc __/__      THC __/__  Cocaine/Crack  __/__  Amphet __/__   Methamph __/__ Heroin __/__   
Methadone  __/__    Other Opiates __/__ Specify:_______________ Benzos  __/__ Barbs __/__         
PCP __/__                 Other: ______     __/__     
Admission drug screen 
CIRCLE ALL POSITIVE 
Alc    THC    Coca    PCP    Amph    Methadone     Opt    BZ   Barb  Other: ___________ 
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AOD Frequency Alc_min / Alc_max =_____/_____ (if min max same – enter twice)  
Drug_frequency (days in a week)=_____ 
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Appendix G 
Informed Consent 
 
 
 
 
 
St. John Health/Providence Hospital and Medical Centers  
CONSENT TO PARTICIPATE IN A RESEARCH STUDY  
AND 
AUTHORIZATION TO USE OR DISCLOSE PROTECTED HEALTH INFORMATION 
FOR RESEARCH 
TO BE CONDUCTED  
AT 
PROVIDENCE HOSPITAL AND MEDICAL CENTERS 
Title:  Prevalence and quality of life among post gastic bypass patients  
in a substance abuse treatment program  
Principal Investigators:  Karen K. Saules, Ph.D., & Denise Bertin-Epp, R.N. 
Office Phone:  Saules 734.487.4988; Bertin-Epp 810.225.2572 
Sub-Investigators and/or Study Staff: Ashley Wiedemann,Valentina Ivezaj,  
Summar Reslan, & Dan Wood 
 This form contains information about a research study.  You understand that you are being 
asked to participate in a research study being conducted through an unfunded collaboration 
between Brighton Hospital and Eastern Michigan University.  If you choose to participate in this 
research study, you should clearly understand all information contained in this consent before 
you agree to participate by signing your name to the last page.  One of the investigators or a 
research assistant will explain the study to you, answer any questions you may have, and witness 
your signature to this consent form.  After you sign the form, you will be given a copy, and an 
additional copy will remain in your medical chart. 
You understand that this is a research study.  You have been asked to participate because you are 
a patient who has reported having had some form of weight-loss (“bariatric”) surgery in the past, 
meet study requirements, and are being seen at Brighton  Hospital and Medical Center.  If you 
have never had weight loss surgery, you are being asked to participate as a comparison, or 
“control”, participant, so that we can compare the experiences of those who have had the surgery 
with those who have not.  
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All subjects participating in research must volunteer, and be informed about the purpose, risks, 
benefits if any, and alternatives.  If you have any questions about this research or the document, 
please ask. 
Background and Purpose 
The purpose of this research study is to gain a better understanding of how common it is for 
individuals who have had weight loss (“bariatric” or “gastric bypass”) surgery to experience 
problems with substance abuse and dependence. We also aim to better understand the factors 
which might contribute to some weight-loss surgery patients being more likely to experience 
substance abuse or dependence.   
Total participation time will be approximately two to three hours, which will include completing 
some questionnaires and an interview. You can choose to do either or both parts of the study (the 
interview and/or the survey), but we hope you will consider doing both.   Both parts are expected 
to take less than one hour each to complete. 
  Check here if you are volunteering to participate in the SURVEY portion of the study. 
 Check here if you are volunteering to participate in the INTERVIEW portion of the study.  
  Control Participant, Interview not applicable (NOTE:  Control participants are not 
eligible for the INTERVIEW part of the study, simply because the interview will be asking about 
experiences directly related to the weight loss surgery itself, which Control participants will not 
have experienced.) 
Study Description, Location, And Duration    
This study is designed to help us to better understand why some weight-loss surgery patients 
encounter problems with alcohol or other drugs.  
You will be asked to complete a survey that will include items about your history of substance 
abuse, weight problems, weight control efforts (including surgery, if applicable), quality of life, 
mood, anxiety, personality, identity, and your physical health.  We estimate that it might take up 
to one hour to complete the survey, but some people may take considerably less time.  
We will gather data from your medical record regarding your diagnoses and progress in 
treatment at Brighton, but this information will be de-identified so that the privacy of your health 
information will be protected.  By this we mean that we will not use information about you that 
could be linked back to your identity.  Once your information leaves Brighton Hospital, there 
will be no way for anyone to figure out who provided it.     
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To help with this process, throughout the study, the researchers ask that you DO NOT put your 
name on any of the study materials, so that your confidentiality can be protected.  We will assign 
a confidential participant identification number to your materials so that we can link them 
together for data analysis purposes.     
If you have ever had bariatric surgery, you will also be asked to participate in an interview 
about the factors that you feel may have contributed to your substance abuse problems and 
reasons for seeking treatment. The antecedents, functions, and consequences of eating and 
substance use behaviors will be assessed during these interviews.  This interview will also take 
about one hour, although we are happy to hear what you have to say if you wish to talk longer.  
We would like to audiotape these interviews so that the information you share can be transcribed 
accurately, but you do not have to agree to taping in order to participate. If you do not wish to be 
taped, the interviewer will simply take notes.  If you agree to be audiotaped, there is a separate 
place for you to sign, giving us permission to do so, at the end of this form.  
We hope to recruit up to 100 men and women in this study.  However, part of the purpose of this 
study is to understand how common it is for weight-loss surgery patients to encounter substance 
use problems.  Because we do not know this, it is difficult to determine how many people will be 
eligible for the study, and how long it might take to enroll them.    
 Possible Risks And Discomforts  
Risks are minimal, aside from the potential for breach of confidentiality. To minimize this risk, 
information which leaves the premises of Brighton Hosptial will not include your name, but will 
instead be labeled with a unique study participation code.   
While risks are anticipated to be minimal, you might still experience some emotional discomfort 
in talking or thinking about the problems you have experienced in both managing your weight 
and controlling substance use.  Upon your request, Dr. Saules can inform Brighton Hospital Staff 
of any distress or concerns you might have so that they can be addressed within the treatment 
program by qualified staff.   
For Women of Childbearing Potential. Because this study only involves talking and filling out 
forms, there are no anticipated risks for your child.  Therefore, even if you are pregnant or 
breast feeding, you may participate in this study.   
Benefits 
There may be no direct benefit to you in participating in the study.  It is possible, however, that 
you might find it interesting to reflect upon your experiences as you answer questions about your 
efforts to control your weight and manage your use of alcohol and/or other drugs.  Participating 
in the study might spark ideas about recovery that you could follow up on with your treatment 
providers at Brighton Hospital.  However, no direct benefits can be guaranteed.  Nonetheless, the 
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information you provide is likely to be of benefit to others who might encounter struggles 
managing weight and addictions in the future.  It is hoped that the information we learn from this 
study will help us to better identify pre-weight-loss-surgery candidates who are at risk for 
developing substance abuse problems and inform efforts to prevent post-surgical problems with 
substance abuse or other addictions.  
Alternative Treatments 
This study does not involve any form of treatment, so there are no alternatives that would be 
appropriate to suggest.  You should not regard the interviews as a form of therapy, although it 
might feel good to have a chance to talk about the problems you have experienced. As noted 
above, if you wish us to release information you tell us to your Brighton Hospital treatment staff, 
we can do that with your permission.  You do not have to participate in this study to continue to 
receive services at Brighton Hospital.  
 Voluntary Participation 
You understand that your participation in this study is voluntary and that your refusal to 
participate will cause no penalty or loss of benefits that you would otherwise receive.  If you 
decide to participate, you may change your mind about being in the study, and may quit at any 
time without penalty or loss of benefits regarding your future care.  If new information becomes 
available during the study that may affect your willingness to continue in the study, your doctor 
and/or his/her associate will discuss this information with you.  Also, your doctor may stop your 
participation at any time if he/she feels that is in your best interest. 
Compensation 
No funds have been set aside for injured research subjects.  While medical care is available 
should an injury occur, the cost will be billed to you or your insurer in the ordinary manner.  You 
will be compensated, however, for taking the time to participate in this study.  If you decide to 
complete the questionnaire packet, you will be given a $10 Target gift card.  If you decide to also 
do the interview, we will give you a second $10 gift card.  You can do either or both of these 
aspects of the study.  We hope that you will consider doing both, so that we can obtain complete 
information about your experiences.    
There are no costs to you for participating in this study.   
Confidentiality Of Records 
The principal investigators will have access to your medical records and your test results.  
While absolute confidentiality cannot be guaranteed, you understand that all medical 
records and research material that could identify you will be kept as confidential as 
possible within state and federal laws.  You also understand that your medical records 
could be examined by the Institutional Review Board (a group of medical and lay people at 
this hospital charged with protecting human subjects’ rights) or government agencies in 
order to verify the data collected during this research study.  If the results of this study are 
presented in any public forum, you will not be identified by name. 
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All responses and personally identifiable information will be kept confidential by being stored in 
separate locked secure cabinets and password protected computer files. You will be given an 
identification number to use throughout the study to protect your confidentiality. However, to 
ensure that you are using the same number throughout the study, the principal investigator will 
keep a log of personally identifiable information and identification numbers. Only the 
investigators will have access to this log, and we will store it in a secure locked cabinet separate 
from your individual responses. Once all data has been collected, this log will be destroyed. 
Information from this study may be reported or published in aggregated form, but you will not be 
identified in any publications or presentations.  
The information you provide strictly for purposes of this research project will NOT be shared 
with Brighton Hospital staff unless you specifically request that we do so, in writing, using 
Brighton Hospital’s standard release of information form.  We are happy to share this 
information with your treatment staff, however, if you wish us to do so and authorize release of 
information.  
Findings from this study may be published in scientific journals and may also be presented at 
professional conferences.  You will not be identified in any of these presentations or 
publications, even if you allow us to quote some of what you tell us.  Instead, we will either 
present information in aggregate (group) form, or we will use an alias (fake name or ID number) 
for you.  
Questions Regarding this Study 
If you have any questions about your rights as a subject in this clinical research study, you may 
contact the IRB (Institutional Review Board) office at 248 849-8889 at Providence Hospital and 
Medical Center. 
If you have any questions regarding the study procedures, your role as a participant, or any injury 
or distress that you feel might be due to study participation, you may contact Dr. Karen Saules 
(734.487.4987 or ksaules@emich.edu) or Denise Bertin-Epp (810.225.2572  or 
depp@brightonhospital.org).  
Authorization to Use and Disclose Protected Health Information (PHI) 
Your participation in this study will require the use and disclosure of certain medical and other 
information about you.  You will not be able to participate if you do not agree to the use and 
disclosure of your information.     
The protected health information (PHI) that may be used or disclosed includes: 
  All information collected during the research study as described in this form,  
  The information that is contained in any medical record that is created during your 
participation in this research, and 
  Other information in your medical record that may be considered related to your participation 
in this research, which may include: your medical history, physical examination results, 
laboratory test results or other test results (like an x-ray, scan, biopsy, EKG). 
Who may see, use, or disclose your PHI:  
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 The researchers and members of the research team    
  Other health care providers or employees of St. John Health who provide services to you for 
this study  
  Representatives of the Institutional Review Board, the FDA (Food and Drug Administration), 
or other governmental agencies involved in research monitoring   
  Members of the safety monitoring board 
  Other agencies as required by law  
 The sponsor, ________________ 
 A clinical research organization, or other agent of the sponsor  
 A laboratory outside of St. John Health System 
What This Authorization Means 
You understand that we cannot guarantee that your protected health information shared or 
disclosed under this Authorization could not be additionally shared or disclosed by the individual 
or organization that receives the information, and the privacy of your PHI may no longer be 
protected by the law. 
You have the right to not agree to disclose your PHI.  However, if you do not agree by signing 
this Authorization, you will not be able to participate in this research study.   
If you do sign below, you have the right to withdraw your permission at any time, but you must 
do so in writing.  You may send the written withdrawal to: 
 Karen K. Saules, Ph.D. 
 Eastern Michigan University 
 Psychology Clinic 
 611 W. Cross St. 
 Ypsilanti, MI  48197 
You may no longer be allowed to participate in the research if you withdraw your permission.  
Also, you understand that any information collected before written notice of withdrawal is 
received will be shared as you have agreed.   
You have the right to review your PHI.  However, if you agree to participate in the research 
study and sign below, you will not be able to look at your research information until the research 
study is completed.    
 
You will receive a copy of this document, the Consent to Participate in a Clinical Research Study 
and Authorization to Use or Disclose Protected Health Information for Research.  
 Expiration Date 
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Your authorization (permission) to use and disclose your health information will continue 
indefinitely, subject to the procedures and limits described in this form. Your health information 
will only be used for the purposes defined within this consent and authorization form. 
Other Considerations 
You have fully discussed and understand the purpose of this clinical research study and how it 
will be carried out.  You have been allowed to ask questions about the study and all of your 
questions have been answered.  You have read this consent form or had the complete form read 
to you and understand it. You know that your participation in this study is fully voluntary and 
you may withdraw at any time.  If you refuse to participate or later withdraw from the study, it 
will not affect your care in any way. You also understand that by consenting to participate in this 
study, you are not waiving any other legal rights you may have because you are a subject in this 
study or as a patient at Providence Hospital & Medical Center. 
Your signature below acknowledges that you voluntarily agree to participate in this clinical 
research study, and you will receive a signed copy of this form. 
_________________________________ _____   _________________ 
Signature of Research Participant      Date 
_________________________________________ 
Printed Name of Research Participant 
_________________________________ _____   __________________ 
*Signature of Witness       Date 
_________________________________ _____   __________________ 
Signature of Person Obtaining Consent 
_________________________________________ 
Printed Name of Person Obtaining Consent 
 
Permission to audiotape:  By signing below, you consent to having you study interview 
audiotaped.  You  understand that the tape will not be associated with your  name or other 
identifying information, and that it will be erased after the information has been transcribed.   
___________________________________  ______________________ 
Participant Signature     Date 
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Permission to quote audiotaped material:   By signing below, you  consent to having the 
investigators quote material from you in presentations or publications.  You understand that these 
quotes will not be associated with your name or other identifying information.  Instead, the 
investigator will make up an alias (a fake name or number) to associate with your comments.  
___________________________________  ______________________ 
Participant Signature     Date 
*Witness 
*Use when participant has had this consent form read to them (i.e., illiterate, legally blind, 
translated into foreign language). 
 
 
 
 
 
